US4012494A
(en)
*
|
1971-12-21 |
1977-03-15 |
Abbott Laboratories |
Direct radioimmunoassay for antigens and their antibodies
|
US3949064A
(en)
*
|
1973-10-26 |
1976-04-06 |
Baxter Laboratories, Inc. |
Method of detecting antigens or antibodies
|
US4172117A
(en)
*
|
1974-05-20 |
1979-10-23 |
Biotest-Serum-Institut Gmbh |
Method for the simultaneous measurement of antigens and their antibodies by solid-phase radioimmunoassay
|
US3959650A
(en)
*
|
1974-08-26 |
1976-05-25 |
Intelcom Rad Tech |
Method for detecting and identifying allergy
|
DK140815B
(da)
*
|
1975-06-10 |
1979-11-19 |
Weeke Bengt |
Fremgangsmåde til påvisning eller bestemmelse af antistoffer i legemsvæsker ved hjælp af kendte antigener eller til bestemmelse af antigener ved hjælp af kendte antistoffer fra legemsvæsker samt et middel til anvendelse ved udøvelse af fremgangsmåden.
|
US4034072A
(en)
*
|
1975-07-21 |
1977-07-05 |
Corning Glass Works |
Serum hepatitis test
|
USRE32696E
(en)
*
|
1975-09-04 |
1988-06-14 |
Akzona Incorporated |
Enzymatic immunological method for determination of antigens and antibodies
|
US4642285A
(en)
*
|
1975-09-29 |
1987-02-10 |
Diamedix Corporation |
Sandwich EIA for antigen
|
SE7610683L
(sv)
*
|
1975-09-29 |
1977-06-10 |
Cordis Corp |
Metod for bestemning av nervaron av ett antigen associerat med hepatit
|
US4474878A
(en)
*
|
1975-09-29 |
1984-10-02 |
Cordis Laboratories, Inc. |
Sandwich EIA for antigen associated with hepatitis
|
GB1533272A
(en)
*
|
1976-02-13 |
1978-11-22 |
Radiochemical Centre Ltd |
Centrifuge tube
|
JPS5851000B2
(ja)
*
|
1976-04-16 |
1983-11-14 |
アボツト ラボラトリ−ズ |
スルホリトコリルグリシルチラミンの製造法
|
US4272510A
(en)
*
|
1976-04-26 |
1981-06-09 |
Smith Kendall O |
Magnetic attraction transfer process for use in solid phase radioimmunoassays and in other assay methods
|
US4120945A
(en)
*
|
1976-07-06 |
1978-10-17 |
Becton, Dickinson & Company |
Substrate coated with receptor and labeled ligand for assays
|
US4210418A
(en)
*
|
1976-08-30 |
1980-07-01 |
Mallinckrodt, Inc. |
Container for immunochemical and enzymatical determinations or procedures
|
GB1572220A
(en)
*
|
1976-10-07 |
1980-07-30 |
Mochida Pharm Co Ltd |
Immunochemical process of measuring physiologically active substances
|
US4090850A
(en)
*
|
1976-11-01 |
1978-05-23 |
E. R. Squibb & Sons, Inc. |
Apparatus for use in radioimmunoassays
|
CA1100037A
(fr)
*
|
1977-03-11 |
1981-04-28 |
Chung-Mei Ling |
Antigene (anti hb.sub.c) depose sur une substance en phase solide
|
US4200613A
(en)
*
|
1977-06-03 |
1980-04-29 |
Ramco Laboratories Inc. |
Radioimmunoassay apparatus
|
US4225575A
(en)
*
|
1978-05-15 |
1980-09-30 |
Ventrex Laboratories, Inc. |
Method and apparatus for performing in vitro clinical diagnostic tests using a solid phase assay system
|
US4197287A
(en)
*
|
1977-06-10 |
1980-04-08 |
Ventrex Laboratories Inc. |
Method and apparatus for performing in nitro clinical diagnostic tests using a solid phase assay system having special utility for use with automatic pipetting equipment
|
US4320087A
(en)
*
|
1978-01-23 |
1982-03-16 |
Abbott Laboratories |
Laboratory assay device
|
US4256629A
(en)
*
|
1978-02-06 |
1981-03-17 |
Research Corporation |
Antigen for early pregnancy test and contraceptive vaccine
|
US4451434A
(en)
*
|
1978-03-27 |
1984-05-29 |
Hiram Hart |
Transparent optical container for non-destructive biological fluid assay
|
US4189464A
(en)
*
|
1978-05-05 |
1980-02-19 |
Institute For Cancer Research |
Hepatitis B testing reagent and method
|
US4292403A
(en)
*
|
1978-08-24 |
1981-09-29 |
Akzona Incorporated |
Detection and/or determination of IgM, IgA, IgD and IgE immunoglobulins
|
US4293538A
(en)
*
|
1979-04-20 |
1981-10-06 |
Merck & Co. Inc. |
Assay for hepatitis A antigen
|
US4356164A
(en)
*
|
1979-05-21 |
1982-10-26 |
Govt. of the U.S., as represented by the Secretary, Dept. of Health & Human Services |
Detection of non-A, non-B hepatitis associated antigen
|
US4289748A
(en)
*
|
1979-05-31 |
1981-09-15 |
United States Of America |
Ultrasensitive enzymatic radioimmunoassay method
|
CA1148859A
(fr)
*
|
1979-06-14 |
1983-06-28 |
Lacy R. Overby |
Technique pour le depistage simultane de deux virus de l'hepatite dans un milieu solide
|
US4378344A
(en)
*
|
1979-09-28 |
1983-03-29 |
Ventrex Laboratories, Inc. |
Method and apparatus for performing multiple, simultaneous in vitro diagnostic tests using a solid phase system
|
US6406920B1
(en)
|
1980-06-20 |
2002-06-18 |
Inverness Medical Switzerland Gmbh |
Processes and apparatus for carrying out specific binding assays
|
EP0111762B1
(fr)
*
|
1980-06-20 |
1987-11-19 |
Unilever Plc |
Procédés et appareil pour l'exécution d'essais de liaisons spécifiques
|
US4363634A
(en)
*
|
1980-07-18 |
1982-12-14 |
Akzona Incorporated |
Glass support coated with synthetic polymer for bioprocess
|
US4357142A
(en)
*
|
1980-07-18 |
1982-11-02 |
Akzona Incorporated |
Glass support coated with synthetic polymer for bioprocess
|
US4376110A
(en)
*
|
1980-08-04 |
1983-03-08 |
Hybritech, Incorporated |
Immunometric assays using monoclonal antibodies
|
US4486530A
(en)
*
|
1980-08-04 |
1984-12-04 |
Hybritech Incorporated |
Immunometric assays using monoclonal antibodies
|
WO1982001773A1
(fr)
*
|
1980-11-07 |
1982-05-27 |
Secher David S |
Analyse pour l'interferon
|
US4474892A
(en)
*
|
1983-02-16 |
1984-10-02 |
Board Of Trustees Of The Leland Stanford Junior University |
Two-site immunoassays using monoclonal antibodies of different classes or subclasses and test kits for performing same
|
US4563184A
(en)
*
|
1983-10-17 |
1986-01-07 |
Bernard Korol |
Synthetic resin wound dressing and method of treatment using same
|
US4861588A
(en)
*
|
1985-02-05 |
1989-08-29 |
New York Blood Center, Inc. |
Pre-S gene coded peptide hepatitis B immunogens, vaccines, diagnostics, and synthetic lipid vesicle carriers
|
US4847080A
(en)
*
|
1984-03-07 |
1989-07-11 |
New York Blood Center, Inc. |
Pre-S gene coded peptide hepatitis B immunogens, vaccines, diagnostics, and synthetic lipide vesicle carriers
|
US5204096A
(en)
*
|
1984-03-07 |
1993-04-20 |
New York Blood Center, Inc. |
Pre-S gene coded peptide hepatitis B immunogens, vaccines, diagnostics, and synthetic lipid vesicle carriers
|
US5158769A
(en)
*
|
1984-03-07 |
1992-10-27 |
New York Blood Center, Inc. |
Pre-S gene coded peptide hepatitis B immunogens, vaccines, diagnostics, and synthetic lipid vesicle carriers
|
US4804626A
(en)
*
|
1986-10-22 |
1989-02-14 |
The General Hospital Corporation |
Immunometric assay for the detection of human chorionic gonadotropin
|
US5061619A
(en)
*
|
1987-11-05 |
1991-10-29 |
Connaught Laboratories Limited |
Immunoassay using antibody-antigen conjugates
|
US5614504A
(en)
*
|
1990-08-01 |
1997-03-25 |
The University Of South Florida |
Method of making inosine monophosphate derivatives and immunopotentiating uses thereof
|
US6168956B1
(en)
|
1991-05-29 |
2001-01-02 |
Beckman Coulter, Inc. |
Multiple component chromatographic assay device
|
US5877028A
(en)
*
|
1991-05-29 |
1999-03-02 |
Smithkline Diagnostics, Inc. |
Immunochromatographic assay device
|
US5998220A
(en)
*
|
1991-05-29 |
1999-12-07 |
Beckman Coulter, Inc. |
Opposable-element assay devices, kits, and methods employing them
|
US5874423A
(en)
*
|
1992-09-10 |
1999-02-23 |
Yissum Research Development Co. Of The Hebrew University Of Jerusalem |
Digitalis-like compounds
|
AU679008B2
(en)
*
|
1993-05-06 |
1997-06-19 |
Chiron Diagnostics Corporation |
Mixed luminescent conjugate test assays
|
WO1995034640A1
(fr)
*
|
1994-06-13 |
1995-12-21 |
Henry Ford Health System |
Neuronatine, nouveau gene neuronal neonatal
|
US6531277B2
(en)
|
1994-10-25 |
2003-03-11 |
The Curators Of The University Of Missouri |
Endometriosis-specific secretory protein
|
US5843673A
(en)
*
|
1994-10-25 |
1998-12-01 |
Curators Of The University Of Missouri |
Method of screening for endometriosis
|
US20030152909A1
(en)
*
|
1994-11-16 |
2003-08-14 |
Mitrani Eduardo N. |
In vitro micro-organs, and uses related thereto
|
US5741462A
(en)
*
|
1995-04-25 |
1998-04-21 |
Irori |
Remotely programmable matrices with memories
|
US5751629A
(en)
*
|
1995-04-25 |
1998-05-12 |
Irori |
Remotely programmable matrices with memories
|
US6329139B1
(en)
|
1995-04-25 |
2001-12-11 |
Discovery Partners International |
Automated sorting system for matrices with memory
|
US5874214A
(en)
*
|
1995-04-25 |
1999-02-23 |
Irori |
Remotely programmable matrices with memories
|
US6331273B1
(en)
|
1995-04-25 |
2001-12-18 |
Discovery Partners International |
Remotely programmable matrices with memories
|
US6017496A
(en)
*
|
1995-06-07 |
2000-01-25 |
Irori |
Matrices with memories and uses thereof
|
US6416714B1
(en)
*
|
1995-04-25 |
2002-07-09 |
Discovery Partners International, Inc. |
Remotely programmable matrices with memories
|
US5777093A
(en)
*
|
1995-05-16 |
1998-07-07 |
Ramot-University Authority For Applied Research & Industrial Development Ltd. |
cDNAs associated with ataxia-telangiectasia
|
US5858661A
(en)
*
|
1995-05-16 |
1999-01-12 |
Ramot-University Authority For Applied Research And Industrial Development |
Ataxia-telangiectasia gene and its genomic organization
|
US5728807A
(en)
*
|
1995-05-16 |
1998-03-17 |
Ramot-University Authority For Applied Research And Industrial Development, Ltd. |
Mutated proteins associated with ataxia-telangiectasia
|
CA2228970A1
(fr)
*
|
1995-08-18 |
1997-02-27 |
Donald W. Landry |
Detection de composes organiques par regulation de reactions catalysees par des anticorps
|
US5840322A
(en)
*
|
1996-12-19 |
1998-11-24 |
Ramot-University Authority For Applied Research & Industrial Devel. Ltd. |
Anti-oral-microbial adhesion fraction derived from vaccinium
|
DE19730497C2
(de)
*
|
1997-07-16 |
2000-02-10 |
Heermann Klaus Hinrich |
Verfahren zum Waschen, zur Separierung und Konzentrierung von Biomolekülen unter Verwendung eines Magnetstifts
|
US7973156B2
(en)
*
|
1997-08-21 |
2011-07-05 |
Quark Pharmaceuticals Inc. |
Hypoxia-regulated genes
|
EP1009753B1
(fr)
|
1997-08-21 |
2005-04-20 |
Quark Biotech, Inc. |
Genes regules au niveau de l'hypoxemie
|
US20030104973A1
(en)
*
|
1997-08-21 |
2003-06-05 |
Quark Biotech, Inc. |
Hypoxia-regulated genes
|
US6284496B1
(en)
|
1997-10-03 |
2001-09-04 |
University Of South Florida |
DNA vector for determining the presence of out-of-reading-frame mutations
|
US6482389B1
(en)
|
1997-10-17 |
2002-11-19 |
University Of South Florida |
Method to diagnose and monitor cellular immune deficiencies
|
US7687057B2
(en)
|
1998-01-09 |
2010-03-30 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
In vitro micro-organs, and uses related thereto
|
US20080206206A1
(en)
|
1998-05-07 |
2008-08-28 |
University Of South Florida |
Bone marrow-derived neuronal cells
|
US6344443B1
(en)
|
1998-07-08 |
2002-02-05 |
University Of South Florida |
Peptide antagonists of tumor necrosis factor alpha
|
WO2000002561A1
(fr)
|
1998-07-13 |
2000-01-20 |
University Of South Florida |
Modulation de la voie de phospholipase a2 utilisee comme procede therapeutique
|
US6187563B1
(en)
|
1998-08-07 |
2001-02-13 |
Yale University |
βIV-spectrin-polypeptides and nucleic acids encoding same
|
IL142094A0
(en)
*
|
1998-09-29 |
2002-03-10 |
Gamida Cell Ltd |
Methods of controlling proliferation and differentiation of stem and progenitor cells
|
EP1147176B1
(fr)
*
|
1999-02-04 |
2009-12-16 |
Pluristem Ltd. |
Methode et appareil de renouvellement et de multiplication de cellules souches hematopoietiques et/ou de progeniteurs
|
US6440682B1
(en)
*
|
1999-05-28 |
2002-08-27 |
Detroit R&D Inc. |
Detection of hypertension using immunoreactive metabolic products
|
US6787318B1
(en)
*
|
1999-06-01 |
2004-09-07 |
Roskamp Research Institute, Llc |
Assay for evaluating the therapeutic effectiveness of agents in reducing Alzheimer's disease pathology
|
US7534605B2
(en)
*
|
1999-06-08 |
2009-05-19 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
CD44 polypeptides, polynucleotides encoding same, antibodies directed thereagainst and method of using same for diagnosing and treating inflammatory diseases
|
CA2435411A1
(fr)
*
|
1999-06-25 |
2001-01-04 |
Yissum Research Development Company Of The Hebrew University Of Jerusale M |
Procede permettant d'induire une angiogenese au moyen de micro-organes
|
US6875582B1
(en)
|
1999-08-19 |
2005-04-05 |
Omniscience Pharmaceuticals, Inc. |
Methods and targets of antibiotic resistance
|
US7811981B2
(en)
*
|
1999-08-30 |
2010-10-12 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Methods of and compositions for inhibiting the proliferation of mammalian cells
|
US7101839B1
(en)
|
1999-08-30 |
2006-09-05 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Methods of and compositions for inhibiting the proliferation of mammalian cells
|
US6998232B1
(en)
|
1999-09-27 |
2006-02-14 |
Quark Biotech, Inc. |
Methods of diagnosing bladder cancer
|
AU784258B2
(en)
|
1999-11-19 |
2006-03-02 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Aspegillus niger beta-glucosidase gene, protein and uses thereof
|
US6544506B2
(en)
*
|
2000-01-05 |
2003-04-08 |
Yeda Research & Development Co. Ltd. |
Veto cells effective in preventing graft rejection and devoid of graft versus host potential
|
AU2001225441A1
(en)
*
|
2000-01-24 |
2001-07-31 |
Agricultural Research Organization The Volcani Center |
Plants tolerant of environmental stress conditions, methods of generating same and novel polynucleotide sequence utilized thereby
|
JP2004503213A
(ja)
|
2000-03-27 |
2004-02-05 |
テクニオン リサーチ アンド ディベロップメント ファウンデーション リミテッド |
1本鎖クラスi主要組織適合性複合体、それをコードする構築物およびそれを生成する方法
|
US20040191260A1
(en)
*
|
2003-03-26 |
2004-09-30 |
Technion Research & Development Foundation Ltd. |
Compositions capable of specifically binding particular human antigen presenting molecule/pathogen-derived antigen complexes and uses thereof
|
IL135884A
(en)
*
|
2000-04-30 |
2005-08-31 |
Yissum Res Dev Co |
Method for measuring non-transferrin bound iron
|
HUP0300810A2
(hu)
|
2000-07-20 |
2003-08-28 |
M.G.V.S. Ltd. |
Mesterséges értranszplantátum, valamint ennek létrehozása és alkalmazása
|
US20040037828A1
(en)
|
2002-07-09 |
2004-02-26 |
Bar-Ilan University |
Methods and pharmaceutical compositions for healing wounds
|
PT2359853E
(pt)
|
2000-08-08 |
2013-12-26 |
Technion Res & Dev Foundation |
Composições farmacêuticas e métodos úteis para a modulação da angiogénese
|
US20030114410A1
(en)
*
|
2000-08-08 |
2003-06-19 |
Technion Research And Development Foundation Ltd. |
Pharmaceutical compositions and methods useful for modulating angiogenesis and inhibiting metastasis and tumor fibrosis
|
EP1683874A3
(fr)
|
2000-08-29 |
2006-10-11 |
YEDA RESEARCH AND DEVELOPMENT Co. LTD. |
Méthode pour l'isolement de gènes codant pour des protéines à fonction spécifique et pour le criblage d'agents pharmaceutiques actifs
|
US7632522B2
(en)
*
|
2000-09-28 |
2009-12-15 |
Nanocyte Inc. |
Use of stinging cells/capsules for the delivery of active agents to keratinous substances
|
US20070281037A9
(en)
*
|
2000-09-28 |
2007-12-06 |
Nanocyte Inc. |
Sterile preparations and compositions including stinging capsules and methods of producing and using same
|
EP1379127B1
(fr)
*
|
2000-09-28 |
2013-04-17 |
Nanocyte Inc. |
Procedes, compositions et dispositifs utilisant des cellules/capsules urticantes pour administrer un agent therapeutique ou cosmetique dans un tissu
|
EP1443970B1
(fr)
|
2000-11-17 |
2010-01-20 |
Vascular Biogenics Ltd. |
Promoteurs presentant une specificite pour des cellules endotheliales et leurs procedes d'utilisation
|
US8071740B2
(en)
|
2000-11-17 |
2011-12-06 |
Vascular Biogenics Ltd. |
Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis
|
IL156015A0
(en)
|
2000-11-24 |
2003-12-23 |
Vascular Biogenics Ltd |
Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis
|
IL155941A0
(en)
*
|
2000-11-30 |
2003-12-23 |
Yeda Res & Dev |
Methods of utilizing cultured non-gvhd inducing t lymphocytes to treat disease
|
JP2004524010A
(ja)
|
2000-11-30 |
2004-08-12 |
モルキューラー スキンケア リミテッド |
疾患の診断および処置
|
CA2475021A1
(fr)
*
|
2001-01-31 |
2002-08-08 |
Dror Mevorach |
Induction de tolerance par des cellules apoptotiques et/ou necrotiques
|
US20050202098A1
(en)
|
2001-01-31 |
2005-09-15 |
Tolaren |
Disease therapy using dying or dead cells
|
US20020117169A1
(en)
*
|
2001-02-27 |
2002-08-29 |
Kurz Daniel R. |
Cover and applicator for a portion of a mammalian body
|
US20030003454A1
(en)
|
2001-03-23 |
2003-01-02 |
Yeda Research And Development Co. Ltd. At The Weizmann Institute Of Science |
Methods and kits for determining a risk to develop cancer, for evaluating an effectiveness and dosage of cancer therapy and for correlating between an activity of a DNA repair enzyme and a cancer
|
US6770622B2
(en)
|
2001-06-08 |
2004-08-03 |
Gary A. Jarvis |
N-terminally truncated galectin-3 for use in treating cancer
|
IL159944A0
(en)
*
|
2001-07-19 |
2004-06-20 |
Yissum Res Dev Co |
Polypeptides having carotenoid isomerase catalytic activity, nucleic acids encoding same and uses thereof
|
AU2002330724A1
(en)
|
2001-08-16 |
2003-03-10 |
Bar Ilan University |
Diagnosis, prevention and treatment of cancer
|
US20040136972A1
(en)
|
2001-09-07 |
2004-07-15 |
Yeda Research And Development Co. Ltd. |
Methods of treating disease by transplantation of developing allogeneic or xenogeneic organs or tissues
|
US7138144B2
(en)
*
|
2001-09-07 |
2006-11-21 |
Nadir Askenasy |
Method of inducing immune tolerance via blood/lymph flow-restricted bone marrow transplantation
|
EP1436313B1
(fr)
|
2001-10-19 |
2010-09-22 |
Vascular Biogenics Ltd. |
Constructions de polynucleotides, compositions pharmaceutiques et procedes de regulation negative de l'angiogenese et de therapie anticancereuse
|
WO2003048298A2
(fr)
*
|
2001-12-05 |
2003-06-12 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Nanoparticules contenant des homologues d'acides nucleiques polymeres, compositions pharmaceutiques et articles fabriques contenant ces nanoparticules, et procedes d'utilisation de celles-ci
|
US20050085432A1
(en)
*
|
2001-12-26 |
2005-04-21 |
Aviva Lapidot |
Methods of using conjugates of saccharides and acetamidino or guanidino compounds for treating bacterial infections
|
IL152904A0
(en)
|
2002-01-24 |
2003-06-24 |
Gamida Cell Ltd |
Utilization of retinoid and vitamin d receptor antagonists for expansion of renewable stem cell populations
|
EP1465982A4
(fr)
*
|
2002-01-25 |
2006-06-07 |
Gamida Cell Ltd |
Methodes de developpement de cellules souches et de cellules precurseurs, populations de cellules multipliees obtenues a l'aide de ces methodes
|
US20040052928A1
(en)
*
|
2002-09-06 |
2004-03-18 |
Ehud Gazit |
Peptides and methods using same for diagnosing and treating amyloid-associated diseases
|
US7781396B2
(en)
*
|
2002-01-31 |
2010-08-24 |
Tel Aviv University Future Technology Development L.P. |
Peptides directed for diagnosis and treatment of amyloid-associated disease
|
US6992176B2
(en)
|
2002-02-13 |
2006-01-31 |
Technion Research & Development Foundation Ltd. |
Antibody having a T-cell receptor-like specificity, yet higher affinity, and the use of same in the detection and treatment of cancer, viral infection and autoimmune disease
|
AU2003216341A1
(en)
*
|
2002-02-20 |
2003-09-09 |
Dyax Corporation |
Mhc-peptide complex binding ligands
|
CA2479679A1
(fr)
*
|
2002-03-18 |
2003-09-25 |
Gamida-Cell Ltd. |
Procedes permettant d'induire la differenciation dans des cellules souches expansees ex vivo
|
WO2003079967A2
(fr)
*
|
2002-03-26 |
2003-10-02 |
Nanocyte Inc. |
Cellules urticantes exprimant un polynucleotide exogene qui code pour un agent therapeutique, diagnostic ou cosmetique, et procedes, compositions et dispositifs faisant intervenir l'utilisation de ces cellules urticantes ou de capsules derivees de celles-ci pour administrer l'agent therapeutique, diagnostic ou cosmetique a
|
US20040121442A1
(en)
*
|
2002-05-05 |
2004-06-24 |
Ilan Chet |
Fungal chitinase, polynucleotide sequences encoding same, promoters of same, and uses thereof
|
EP1534345A4
(fr)
*
|
2002-07-12 |
2012-03-21 |
Yissum Res Dev Co |
Methode et dispositif d'induction de processus biologiques par des micro-organismes
|
CA2494348C
(fr)
|
2002-08-01 |
2014-04-08 |
Yeda Research And Development Co. Ltd. |
Methode et composition pour la protection du tissu neuronal contre une lesion induite par des taux de glutamate eleves
|
US7267981B2
(en)
|
2002-10-07 |
2007-09-11 |
Technion Research & Development Foundation Ltd. |
Human foreskin fibroblasts for culturing ES cells
|
CA2501330A1
(fr)
*
|
2002-10-11 |
2004-04-22 |
Sentina Biotechnology Incorporated |
Methodes de detection du cancer du sein
|
US20040146949A1
(en)
*
|
2002-10-25 |
2004-07-29 |
Jun Tan |
Methods and compounds for disruption of CD40R/CD40L signaling in the treatment of alzheimer's disease
|
WO2004040252A2
(fr)
|
2002-10-30 |
2004-05-13 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Molecules et leurs procedes d'utilisation pour la mesure de fer non lie par la transferrine
|
US20050054097A1
(en)
*
|
2002-11-17 |
2005-03-10 |
Tony Peled |
EX-VIVO expansion of hematopoietic system cell populations in mononuclear cell cultures
|
AU2003302701A1
(en)
*
|
2002-11-29 |
2004-06-23 |
Technion Research And Development Foundation Ltd. |
Method of dynamically culturing embryonic stem cells
|
US7491699B2
(en)
|
2002-12-09 |
2009-02-17 |
Ramot At Tel Aviv University Ltd. |
Peptide nanostructures and methods of generating and using the same
|
CN101297789B
(zh)
|
2002-12-12 |
2013-01-02 |
R.B.T.(洛东生物科技)有限公司 |
木质素过氧化物酶的生产方法及其在皮肤和毛发增亮中的应用
|
HUE028026T2
(en)
|
2002-12-16 |
2016-11-28 |
Technion Res & Dev Foundation |
Breeding system free of native cells, free of foreign matter for human embryonic stem cells
|
EP1587953B1
(fr)
|
2003-01-02 |
2012-02-22 |
Rappaport Family Institute for Research in the Medical Sciences |
Methodes de prediction de potentiel a tirer benefice d'un traitement antioxydant pour la prevention de maladies cardiovasculaires chez des patients hyperglycemiques
|
ATE426575T1
(de)
|
2003-01-07 |
2009-04-15 |
Univ Ramot |
Peptidenanostrukturen die fremdmaterial enthalten,und verfahren zur herstellung derselben
|
EP1599598A4
(fr)
|
2003-03-04 |
2007-08-08 |
Yeda Res & Dev |
Polypeptides pon, polynucleotides les codant et compositions et procedes utilisant ces derniers
|
US20050054103A1
(en)
*
|
2003-03-07 |
2005-03-10 |
Tony Peled |
Expansion of renewable stem cell populations using modulators of PI 3-kinase
|
US8017113B2
(en)
|
2003-03-12 |
2011-09-13 |
Rappaport Family Institute For Research In The Medical Sciences |
Compositions and methods for diagnosing and treating an inflammation
|
US7294701B2
(en)
*
|
2003-04-02 |
2007-11-13 |
Technion Research & Development Foundation Ltd. |
Antibody fragment capable of modulating multidrug resistance and compositions and kits and methods using same
|
DK2330132T3
(da)
|
2003-04-04 |
2013-11-04 |
Yeda Res & Dev |
Antistoffer mod MMP2 eller MMP9 og farmaceutiske sammensætninger deraf til hæmning af deres metalloproteinaktivitet
|
ES2559053T3
(es)
|
2003-04-08 |
2016-02-10 |
Yeda Research And Development Co., Ltd. |
Células madre con aumento de sensibilidad a SDF-1 y procedimientos de generación y utilización de las mismas
|
FR2853551B1
(fr)
|
2003-04-09 |
2006-08-04 |
Lab Francais Du Fractionnement |
Formulation stabilisante pour compositions d'immunoglobulines g sous forme liquide et sous forme lyophilisee
|
US7321065B2
(en)
*
|
2003-04-18 |
2008-01-22 |
The Regents Of The University Of California |
Thyronamine derivatives and analogs and methods of use thereof
|
US7554007B2
(en)
*
|
2003-05-22 |
2009-06-30 |
Evogene Ltd. |
Methods of increasing abiotic stress tolerance and/or biomass in plants
|
BR122016024209B1
(pt)
|
2003-05-22 |
2019-08-20 |
Evogene Ltd. |
Método para aumentar a biomassa e/ou tolerância de uma planta ao estresse salino e construto de ácido nucleico
|
AU2005234725B2
(en)
|
2003-05-22 |
2012-02-23 |
Evogene Ltd. |
Methods of Increasing Abiotic Stress Tolerance and/or Biomass in Plants and Plants Generated Thereby
|
US20050020499A1
(en)
*
|
2003-05-27 |
2005-01-27 |
Bar Ilan University |
Methods of attenuating cocaine seeking behavior employing glial cell-derived neurotrophic factor (GDNF) and pharmaceutical compositions and articles of manufacture suited for use in practice of the method
|
US7498428B2
(en)
*
|
2003-06-19 |
2009-03-03 |
Evogene Ltd. |
Nucleotide sequences for regulating gene expression in plant trichomes and constructs and methods utilizing same
|
US8129514B2
(en)
*
|
2003-06-19 |
2012-03-06 |
Evogene Ltd. |
Nucleotide sequences for regulating gene expression in plant trichomes and constructs and methods utilizing same
|
CA2530927A1
(fr)
|
2003-06-30 |
2005-01-06 |
Tel Aviv University Future Technology Development L.P. |
Peptides, anticorps diriges contre les maladies associees a l'amyloide et procedes d'utilisation pour le diagnostic et le traitement de ces maladies
|
WO2005019417A2
(fr)
*
|
2003-08-14 |
2005-03-03 |
The Bio Balance Corporation |
Souches bacteriennes, compositions les comprenant et leur utilisation dans un traitement probiotique
|
WO2005031362A2
(fr)
|
2003-10-02 |
2005-04-07 |
Ramot At Tel Aviv University Ltd. |
Nouveaux agents antibacteriens et procedes permettant de les identifier et de les utiliser
|
WO2005033145A1
(fr)
|
2003-10-07 |
2005-04-14 |
Yeda Research And Development Co. Ltd. |
Anticorps diriges contre nik, preparation et emploi
|
IL158287A0
(en)
|
2003-10-07 |
2004-05-12 |
Yeda Res & Dev |
Antibodies to nik, their preparation and use
|
RU2006113588A
(ru)
*
|
2003-10-23 |
2006-08-10 |
Пфайзер Продактс Инк. (Us) |
Вакцина для периодонтального заболевания
|
AU2004292872B2
(en)
|
2003-11-30 |
2012-04-19 |
Yeda Research And Development Co. Ltd |
Methods and agents for immune modulation and methods for identifying immune modulators
|
WO2005059100A2
(fr)
*
|
2003-12-12 |
2005-06-30 |
New York University |
Procedes et compositions se rapportant a la cystatine c
|
US20100221233A1
(en)
*
|
2003-12-15 |
2010-09-02 |
University Of South Florida |
Compositions and methods for enhancing neuroprotection via administration of stem cells and blood brain barrier permeabilizers
|
DK1722834T3
(da)
|
2003-12-22 |
2012-10-22 |
Regentis Biomaterials Ltd |
Matrix, som omfatter naturligt forekommende tværbundet proteinskelet
|
EP2251695B1
(fr)
|
2003-12-23 |
2013-07-17 |
Mount Sinai Hospital Corporation |
Marqueurs associees a la maladie de l'endometre
|
US8007847B2
(en)
*
|
2004-01-13 |
2011-08-30 |
Eytan Biderman |
Feeding formula appliance
|
US7423139B2
(en)
*
|
2004-01-20 |
2008-09-09 |
Insight Biopharmaceuticals Ltd. |
High level expression of recombinant human erythropoietin having a modified 5′-UTR
|
EP1713900A4
(fr)
*
|
2004-01-27 |
2009-06-17 |
Compugen Ltd |
Procedes et systemes pour l'annotation de sequences de biomolecules
|
JP2007526337A
(ja)
|
2004-03-02 |
2007-09-13 |
アクセルロン ファーマ インコーポレーテッド |
Alk7およびミオスタチン阻害剤ならびにその使用
|
US8352031B2
(en)
|
2004-03-10 |
2013-01-08 |
Impulse Dynamics Nv |
Protein activity modification
|
WO2005115394A2
(fr)
*
|
2004-04-20 |
2005-12-08 |
New York University School Of Medicine |
Commutateur electrostatique prenyle et procedes d'utilisation
|
ES2665463T3
(es)
|
2004-06-14 |
2018-04-25 |
Evogene Ltd. |
Polinucleótidos y polipéptidos implicados en el desarrollo de fibra vegetal y métodos de uso de los mismos
|
US8680062B2
(en)
*
|
2004-07-06 |
2014-03-25 |
Deliversir Ltd. |
System for delivering therapeutic agents into living cells and cells nuclei
|
US20090156471A1
(en)
*
|
2004-07-15 |
2009-06-18 |
Ramot At Tel Aviv University Ltd. |
Use of anti-amyloid agents for treating and typing pathogen infections
|
US8568637B2
(en)
|
2004-08-02 |
2013-10-29 |
Ramot At Tel-Aviv University Ltd. |
Method of forming a fiber made of peptide nanostructures
|
WO2006027780A2
(fr)
|
2004-09-08 |
2006-03-16 |
Ramot At Tel Aviv University Ltd. |
Nanostructures peptidiques contenant des peptides modifies par coiffage terminal, et procedes de generation et d'utilisation de celles-ci
|
EP1799812A4
(fr)
*
|
2004-09-16 |
2009-09-09 |
Gamida Cell Ltd |
Méthodes de culture ex vivo de cellules souches et de précurseur par co-culture avec des cellules mésenchymales
|
CA2582051C
(fr)
|
2004-09-29 |
2015-08-11 |
Collplant Ltd. |
Collagene de recombinaison produit dans une plante
|
CA2582041C
(fr)
*
|
2004-09-29 |
2015-08-04 |
Levava Roiz |
Rnase t2 humaine recombinee et utilisations associees
|
US7781402B2
(en)
*
|
2004-10-12 |
2010-08-24 |
Closed Loop Therapies Ltd. |
Methods and implantable devices for treating supraventricular arrhythmias
|
US20060134680A1
(en)
*
|
2004-12-22 |
2006-06-22 |
Alexander Kotlyar |
Homogeneous populations of nucleic acids, methods of synthesyzing same and uses thereof
|
EP1872604A4
(fr)
*
|
2005-01-16 |
2010-01-20 |
Zlango Ltd |
Systeme de reseau de communication et procedes d'utilisation
|
JP2008527563A
(ja)
*
|
2005-01-16 |
2008-07-24 |
ズランゴー リミテッド |
アイコニック通信
|
US8019818B2
(en)
*
|
2005-01-18 |
2011-09-13 |
Zlango Ltd. |
Communications network system and methods for using same
|
US9101927B2
(en)
|
2005-01-31 |
2015-08-11 |
Realbio Technologies Ltd. |
Multistep reaction lateral flow capillary device
|
US8257742B2
(en)
|
2005-02-17 |
2012-09-04 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Bisphosphonates for treating endometriosis
|
US8216801B2
(en)
|
2005-02-25 |
2012-07-10 |
The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization, (A.R.O.), The Volcani Center |
Methods for treating inflammatory disorders
|
US7695927B2
(en)
*
|
2005-03-18 |
2010-04-13 |
Detroit R & D |
Detection of hypertension using glucuronidated metabolic products
|
WO2006109312A2
(fr)
*
|
2005-04-15 |
2006-10-19 |
Vascular Biogenics Ltd. |
Compositions contenant des peptides derives de la glycoproteine i beta 2 pour la prevention et le traitement de maladie cardiovasculaire
|
US8834862B2
(en)
*
|
2005-04-19 |
2014-09-16 |
Nanocyte Inc. |
Methods, compositions and devices utilizing stinging cells/capsules for conditioning a tissue prior to delivery of an active agent
|
EP1888034A2
(fr)
|
2005-05-26 |
2008-02-20 |
Yissum Research Development Company, of The Hebrew University of Jerusalem |
Compositions et methodes d'utilisation desdites compositions dans l'administration d'agents dans un organe cible protege par une barriere sanguine
|
JP2008546385A
(ja)
|
2005-06-16 |
2008-12-25 |
ラモト アット テル アヴィヴ ユニヴァーシティ リミテッド |
Cns疾患を治療するための単離された細胞および単離された細胞を含む集団
|
US20070225242A1
(en)
*
|
2005-06-21 |
2007-09-27 |
The Board Of Trustees Of The Leland Stanford Junior University |
Method and composition for treating and preventing tumor metastasis in vivo
|
US9051379B2
(en)
|
2005-07-07 |
2015-06-09 |
Fulcrum Sp Ltd. |
Sp1 polypeptides, modified Sp1 polypeptides and uses thereof
|
CN101273130B
(zh)
*
|
2005-07-07 |
2012-05-30 |
耶路撒冷希伯来大学伊森姆研究发展公司 |
用于下调h19的核酸物质及其使用方法
|
CN101278052A
(zh)
|
2005-07-18 |
2008-10-01 |
普罗塔里克斯有限公司 |
生物活性大分子的粘膜或肠给药
|
EP1945257A4
(fr)
*
|
2005-08-08 |
2009-05-06 |
Onconon Llc |
Compositions d'anticorps, methodes de traitement de maladie neoplasique et methodes de regulation de la fertilite
|
WO2007023491A2
(fr)
|
2005-08-24 |
2007-03-01 |
Yeda Research And Development Co. Ltd. |
Cellules tolerogeniques derivees de donneurs universels et destinees a induire une tolerance a la transplantation non syngenique
|
WO2007026353A2
(fr)
|
2005-08-29 |
2007-03-08 |
Technion Research & Development Foundation Ltd. |
Milieux de culture de cellules souches
|
US8034914B2
(en)
*
|
2005-09-22 |
2011-10-11 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Nucleic acid constructs, pharmaceutical compositions and methods of using same for treating cancer
|
WO2007043048A2
(fr)
*
|
2005-10-11 |
2007-04-19 |
Ramot At Tel Aviv University Ltd. |
Hydrogels auto-assembles et leurs procedes d'elaboration et d'utilisation
|
US20070087437A1
(en)
*
|
2005-10-14 |
2007-04-19 |
Jifan Hu |
Methods for rejuvenating cells in vitro and in vivo
|
BRPI0618965B1
(pt)
|
2005-10-24 |
2021-01-12 |
Evogene Ltd |
método para aumentar a tolerância de uma planta a uma condição de estresse abiótico, método para aumentar a biomassa, vigor e/ou rendimento de uma planta, método para aumentar a eficiência do uso de fertilizante e/ou absorção de uma planta
|
US7879212B2
(en)
*
|
2005-11-03 |
2011-02-01 |
Ramot At Tel-Aviv University Ltd. |
Peptide nanostructure-coated electrodes
|
US8846393B2
(en)
|
2005-11-29 |
2014-09-30 |
Gamida-Cell Ltd. |
Methods of improving stem cell homing and engraftment
|
WO2007063545A2
(fr)
|
2005-11-29 |
2007-06-07 |
Gamida-Cell Ltd. |
Methodes d'amelioration de prise de greffe et de nostocytose de cellules souches
|
US8775526B2
(en)
|
2006-01-16 |
2014-07-08 |
Zlango Ltd. |
Iconic communication
|
US7553941B2
(en)
|
2006-02-03 |
2009-06-30 |
Modigene Inc |
Long-acting polypeptides and methods of producing same
|
US8946155B2
(en)
|
2006-02-03 |
2015-02-03 |
Opko Biologics Ltd. |
Long-acting polypeptides and methods of producing and administering same
|
US10221228B2
(en)
|
2006-02-03 |
2019-03-05 |
Opko Biologics Ltd. |
Long-acting polypeptides and methods of producing and administering same
|
US20140113860A1
(en)
|
2006-02-03 |
2014-04-24 |
Prolor Biotech Ltd. |
Long-acting polypeptides and methods of producing and administering same
|
US8048849B2
(en)
|
2006-02-03 |
2011-11-01 |
Modigene, Inc. |
Long-acting polypeptides and methods of producing same
|
US8450269B2
(en)
|
2006-02-03 |
2013-05-28 |
Prolor Biotech Ltd. |
Long-acting growth hormone and methods of producing same
|
US20150038413A1
(en)
|
2006-02-03 |
2015-02-05 |
Opko Biologics Ltd. |
Long-acting polypeptides and methods of producing and administering same
|
US8048848B2
(en)
|
2006-02-03 |
2011-11-01 |
Prolor Biotech Ltd. |
Long-acting interferons and derivatives thereof and methods thereof
|
US8759292B2
(en)
|
2006-02-03 |
2014-06-24 |
Prolor Biotech, Llc |
Long-acting coagulation factors and methods of producing same
|
US10351615B2
(en)
|
2006-02-03 |
2019-07-16 |
Opko Biologics Ltd. |
Methods of treatment with long-acting growth hormone
|
US9458444B2
(en)
|
2006-02-03 |
2016-10-04 |
Opko Biologics Ltd. |
Long-acting coagulation factors and methods of producing same
|
US9249407B2
(en)
|
2006-02-03 |
2016-02-02 |
Opko Biologics Ltd. |
Long-acting coagulation factors and methods of producing same
|
US8476234B2
(en)
|
2006-02-03 |
2013-07-02 |
Prolor Biotech Inc. |
Long-acting coagulation factors and methods of producing same
|
JP2009526219A
(ja)
|
2006-02-06 |
2009-07-16 |
ラパポート ファミリー インスティテュート フォー リサーチ イン ザ メディカル サイエンシーズ |
T1dmを診断するための方法及びキット
|
US8124107B2
(en)
*
|
2006-02-22 |
2012-02-28 |
The Texas A&M University System |
Antibodies recognizing a highly expressed putative antigen of CA-MRSA and methods of use
|
ES2553637T3
(es)
|
2006-03-06 |
2015-12-10 |
Zetiq Technologies Ltd. |
Métodos para identificar un fenotipo celular
|
AU2007228341B2
(en)
|
2006-03-23 |
2013-10-17 |
Pluri Biotech Ltd |
Methods for cell expansion and uses of cells and conditioned media produced thereby for therapy
|
EP2004858A4
(fr)
|
2006-03-28 |
2009-12-09 |
Tel Hashomer Medical Res Infrastructure & Services Ltd |
Procedes et kits pour determiner la predisposition a la resistance a la warfarine
|
MX2008012754A
(es)
*
|
2006-04-07 |
2009-04-27 |
Us Gov Health & Human Serv |
Composiciones de anticuerpos y metodos para tratamiento de enfermedad neoplastica.
|
JP5225266B2
(ja)
*
|
2006-05-19 |
2013-07-03 |
テバ ファーマシューティカル インダストリーズ リミティド |
融合タンパク質、その使用、およびその製造方法
|
US20070281883A1
(en)
*
|
2006-06-05 |
2007-12-06 |
Hanna Rosenfeld |
Development of follicle stimulating hormone agonists and antagonists in fish
|
WO2008010228A2
(fr)
|
2006-07-20 |
2008-01-24 |
Yeda Research And Development Co. Ltd. |
Organismes photosynthétiques, compositions et procédés de génération desdits organismes
|
WO2008026198A2
(fr)
|
2006-08-28 |
2008-03-06 |
Yeda Research And Development Co. Ltd. |
Méthodes de production de cellules gliales et neuronales et leur utilisation pour le traitement de troubles médicaux du système nerveux central
|
ES2426754T3
(es)
|
2006-10-05 |
2013-10-25 |
Technion Research & Development Foundation Ltd. |
Microtubos y métodos para producirlos
|
US7888059B2
(en)
*
|
2006-10-05 |
2011-02-15 |
Yeda Research And Development Co. Ltd. |
Highly purified and stabilized Na,K-ATPase isoforms and methods of producing same
|
EP2087152B1
(fr)
|
2006-10-27 |
2015-03-11 |
Walfish, Paul |
Biomarqueurs endométriaux
|
US20080131954A1
(en)
*
|
2006-11-30 |
2008-06-05 |
Canon U.S. Life Sciences, Inc. |
Method of Separating Target DNA from Mixed DNA
|
AU2007335706B2
(en)
|
2006-12-20 |
2013-03-28 |
Evogene Ltd. |
Polynucleotides and polypeptides involved in plant fiber development and methods of using same
|
EP2111450A2
(fr)
*
|
2007-01-16 |
2009-10-28 |
Yissum Research Development Company of the Hebrew University of Jerusalem |
Acides nucléiques recombinés et procédés de silençage spécifique de h19
|
WO2008093331A1
(fr)
*
|
2007-01-29 |
2008-08-07 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Conjugues d'anticorps pour vaincre la multiresistances aux medicaments
|
WO2008093341A2
(fr)
|
2007-01-31 |
2008-08-07 |
Technion Research & Development Foundation Ltd. |
Échafaudages électrofilés et leurs procédés de génération et d'utilisation
|
WO2008093342A2
(fr)
|
2007-02-01 |
2008-08-07 |
Technion Research & Development Foundation Ltd. |
Fibres et tissus d'albumine et leurs procédés de génération et d'utilisation
|
US8748371B2
(en)
|
2007-02-28 |
2014-06-10 |
Yeda Research And Development Co. Ltd. |
Nuclear targeting sequences
|
US20100158927A1
(en)
|
2007-03-29 |
2010-06-24 |
Technion Research & Development Foundation Ltd. |
Antibodies, methods and kits for diagnosing and treating melanoma
|
JP2010523104A
(ja)
|
2007-04-02 |
2010-07-15 |
ラモット・アット・テル・アビブ・ユニバーシテイ・リミテッド |
ガン細胞検出方法ならびにガン疾患の診断およびガン疾患の処置のモニタリングのためのその使用
|
EP2154946B1
(fr)
|
2007-04-09 |
2013-06-05 |
Evogene Ltd. |
Polynucléotides, polypeptides et procédés permettant d'augmenter la teneur en huile, la vitesse de croissance et la biomasse de plantes
|
WO2008129548A2
(fr)
|
2007-04-23 |
2008-10-30 |
Segev Laboratories Limited |
Système pour administrer des agents thérapeutiques dans des cellules vivantes et noyaux de cellules
|
US9156865B2
(en)
|
2007-04-23 |
2015-10-13 |
Deliversir Ltd |
System for delivering therapeutic agents into living cells and cells nuclei
|
US9556210B2
(en)
|
2007-04-23 |
2017-01-31 |
Sabag-Rfa Ltd. |
System for delivering therapeutic agents into living cells and cells nuclei
|
WO2008132753A2
(fr)
|
2007-05-01 |
2008-11-06 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Procédés et trousses de détection de cellules fœtales dans le sang maternel
|
WO2008136774A1
(fr)
|
2007-05-03 |
2008-11-13 |
Agency For Science, Technology And Research |
Fixation d'anticorps sur un polypeptide prl-1 ou prl-3 intracellulaire
|
EP2150608B1
(fr)
|
2007-05-07 |
2017-11-29 |
Protalix Ltd. |
Bioréacteur jetable à grande échelle
|
WO2008141318A1
(fr)
*
|
2007-05-14 |
2008-11-20 |
Dr. Susan Love Research Foundation |
Dispositif de détermination du risque de développement du cancer du sein et procédé pour celui-ci
|
US20100197767A1
(en)
|
2007-07-11 |
2010-08-05 |
Lior Nissim |
Nucleic acid construct systems capable of daignosing or treating a cell state
|
IL184627A0
(en)
|
2007-07-15 |
2008-12-29 |
Technion Res & Dev Foundation |
Agents for diagnosing and modulating metastasis and fibrosis as well as inflammation in a mammalian tissue
|
WO2009010968A2
(fr)
|
2007-07-15 |
2009-01-22 |
Yitzchak Hillman |
Traitement de maladie par des peptides antimicrobien ou leurs inhibiteurs
|
EP2183371B1
(fr)
|
2007-07-24 |
2015-07-01 |
Evogene Ltd. |
Polynucleotides, polypeptides codes par ceux-ci, et leurs procedes d'utilisation pour augmenter la tolerance au stress abiotique et/ou la biomasse et/ou le rendement dans des plantes les exprimant
|
AU2008299784B9
(en)
|
2007-08-02 |
2015-06-18 |
Gilead Biologics, Inc. |
LOX and LOXL2 inhibitors and uses thereof
|
CA2695969A1
(fr)
|
2007-08-15 |
2009-02-19 |
Yeda Research & Development Co. Ltd. |
Regulateurs de la mmp-9 et leurs utilisations
|
CN101855549A
(zh)
|
2007-09-12 |
2010-10-06 |
耶达研究及发展有限公司 |
在免疫豁免部位内治疗肿瘤的方法
|
RU2010109698A
(ru)
|
2007-09-19 |
2011-09-27 |
Плуристем Лтд. (Il) |
Адгезивные клетки жировой ткани или плаценты и их использование в лечебных целях
|
EP2210092B1
(fr)
|
2007-10-19 |
2014-06-11 |
Rappaport Family Institute for Research in the Medical Sciences |
Compositions comprenant des sémaphorines pour le traitement de maladies associées à l'angiogenèse et leurs procédés de sélection
|
WO2009069123A2
(fr)
|
2007-11-26 |
2009-06-04 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Compositions renfermant des polypeptides fibreux et des polysaccharides
|
MX357387B
(es)
|
2007-12-27 |
2018-07-06 |
Evogene Ltd |
Polipeptidos, polinucleotidos aislados utiles para modificar la eficacia en el uso de agua, eficacia en el uso del fertilizante, la tolerancia al estres biotico/abiotico, el rendimiento y biomasa en plantas.
|
US20110052501A1
(en)
*
|
2008-01-31 |
2011-03-03 |
Liat Dassa |
Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics
|
CA2618163A1
(fr)
|
2008-02-07 |
2009-08-07 |
K. W. Michael Siu |
Biomarqueurs de cancer de la tete et du cou
|
EP2250302B1
(fr)
|
2008-02-21 |
2014-05-21 |
Technion Research and Development Foundation, Ltd. |
Utilisation de microtubes électrofilés pour l'administration de médicaments
|
US8747855B2
(en)
*
|
2008-04-09 |
2014-06-10 |
Technion Research & Development Foundation Limited |
Anti human immunodeficiency antibodies and uses thereof
|
WO2009125381A1
(fr)
*
|
2008-04-10 |
2009-10-15 |
Objet Geometries Ltd. |
Système et procédé pour l’impression de modèles en trois dimensions
|
CN102056619A
(zh)
|
2008-04-18 |
2011-05-11 |
科尔普兰特有限公司 |
产生和使用原胶原的方法
|
ES2551318T3
(es)
|
2008-04-21 |
2015-11-18 |
Danziger Innovations Ltd. |
Vectores de expresión virales de plantas y uso de los mismos para generar variaciones genotípicas en genomas de plantas
|
SG196839A1
(en)
|
2008-04-25 |
2014-02-13 |
Dyax Corp |
Antibodies against fcrn and use thereof
|
EP2116618A1
(fr)
|
2008-05-09 |
2009-11-11 |
Agency for Science, Technology And Research |
Diagnostic et traitement de la maladie de Kawasaki
|
CA3148194A1
(fr)
*
|
2008-05-22 |
2009-11-26 |
Evogene Ltd. |
Polynucleotides et polypeptides isoles et leurs procedes d'utilisation pour augmenter le rendement vegetal, la biomasse, la vitesse de croissance, la vigueur, la teneur en huile, la tolerance au stress abiotique des plantes et l'efficacite d'utilisation de l'azote
|
CA2725637A1
(fr)
|
2008-05-27 |
2009-12-03 |
Pluristem Ltd. |
Procedes de traitement de maladies inflammatoires du colon
|
US8663987B2
(en)
|
2008-05-28 |
2014-03-04 |
Ramot At Tel-Aviv University Ltd. |
Mesenchymal stem cells for the treatment of CNS diseases
|
EP2599793A1
(fr)
|
2008-05-29 |
2013-06-05 |
Nuclea Biotechnologies, Inc. |
Anticorps anti-phospho-akt
|
CN102076415B
(zh)
|
2008-06-29 |
2015-06-24 |
瑞尔比奥技术有限公司 |
尤其可用作生物测定过程中的捕捉装置的液体转移装置
|
AU2009279458B2
(en)
|
2008-08-08 |
2015-07-02 |
Code Biotherapeutics, Inc. |
Long-acting DNA dendrimers and methods thereof
|
GB2474807A
(en)
|
2008-08-08 |
2011-04-27 |
Agency Science Tech & Res |
Vhz for diagnosis and treatment of cancers
|
BR122021014165B1
(pt)
|
2008-08-18 |
2022-08-16 |
Evogene Ltd. |
Método para aumentar a eficiência de uso do nitrogênio, eficiência de uso de fertilizantes, produção, biomassa e/ou tolerância ao estresse por deficiência de nitrogênio e seca de uma planta, e, construção de ácido nucleico isolado
|
CA2735790C
(fr)
|
2008-09-02 |
2017-02-28 |
Pluristem Ltd. |
Cellules adherentes provenant d'un tissu placentaire et leur utilisation en therapie
|
US8367392B2
(en)
*
|
2008-09-05 |
2013-02-05 |
Transalgae Ltd. |
Genetic transformation of algal and cyanobacteria cells by microporation
|
WO2010029545A2
(fr)
|
2008-09-11 |
2010-03-18 |
Ben Gurion University Of The Negev Research And Development Authority |
Compositions et procédés destinés à traiter une infection par s. pneumoniae
|
CN107595889A
(zh)
|
2008-09-12 |
2018-01-19 |
克里奥普拉斯低温生物有限公司 |
缺血性组织的细胞疗法
|
CN102171239B
(zh)
|
2008-09-24 |
2018-11-13 |
特尔哈肖梅尔医学研究基础设施和服务有限公司 |
用于防止细胞粘附的肽和组合物及其使用方法
|
CA2736729A1
(fr)
|
2008-09-29 |
2010-04-01 |
Ben Gurion University Of The Negev Research And Development Authority |
Beta-peptides amyloides et procedes d'utilisation associes
|
US8921658B2
(en)
|
2008-10-30 |
2014-12-30 |
Evogene Ltd. |
Isolated polynucleotides encoding a MAP65 polypeptide and methods of using same for increasing plant yield
|
US20110229892A1
(en)
|
2008-11-17 |
2011-09-22 |
Yehuda G Assaraf |
Method for predicting a patient's responsiveness to anti-folate therapy
|
WO2010058396A1
(fr)
|
2008-11-19 |
2010-05-27 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Anticorps anti-cd44vra et procédés diagnostiques et thérapeutiques l'utilisant
|
WO2010061383A1
(fr)
|
2008-11-26 |
2010-06-03 |
Biodalia Microbiological Technologies Ltd. |
Procédé permettant d’enrichir in-situ des aliments avec des fructanes
|
WO2010064231A1
(fr)
|
2008-12-02 |
2010-06-10 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Procédés d’analyse d’édition d’arn a-i et constructions d’acide nucléique capables de ceux-ci
|
US20120014927A1
(en)
|
2008-12-03 |
2012-01-19 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Methods and kits for determining predisposition to cancer
|
WO2010064248A2
(fr)
|
2008-12-05 |
2010-06-10 |
Yeda Research And Development Co. Ltd. |
Procédés de diagnostic et de traitement des maladies des motoneurones
|
WO2010071610A1
(fr)
|
2008-12-19 |
2010-06-24 |
Agency For Science, Technology And Research (A*Star) |
Marqueurs biologiques de chikungunya sévère
|
AR074925A1
(es)
|
2008-12-29 |
2011-02-23 |
Evogene Ltd |
Polinucleotidos, polipeptidos codificados, y metodos para utilizarlos para modular la tolerancia al estres abiotico, biomasa y/o rendimiento en plantas que los expresan
|
WO2010076788A2
(fr)
|
2008-12-29 |
2010-07-08 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Méthodes de prédiction de la réponse au traitement par un interféron et traitement d'une infection par l'hépatite c
|
WO2010076642A1
(fr)
|
2008-12-29 |
2010-07-08 |
Tel Hashomer Medical Research, Infrastructure And Services Ltd |
Peptides et compositions pour prévenir l'adhésion cellulaire et leurs procédés d'utilisation
|
WO2010076794A1
(fr)
|
2008-12-31 |
2010-07-08 |
Technion Research & Development Foundation Ltd. |
Procédé pour dénitrifier une saumure et systèmes aptes à une telle dénitrification
|
US9107935B2
(en)
*
|
2009-01-06 |
2015-08-18 |
Gilead Biologics, Inc. |
Chemotherapeutic methods and compositions
|
IL196820A0
(en)
|
2009-02-01 |
2009-11-18 |
Yissum Res Dev Co |
Devitalized, acellular scaffold matrices derived from micro-organs seeded with various cells
|
US8691760B2
(en)
|
2009-02-02 |
2014-04-08 |
Ramot At Tel-Aviv University |
Peptides, pharmaceutical compositions comprising same and uses thereof
|
WO2010089707A1
(fr)
|
2009-02-04 |
2010-08-12 |
Yeda Research And Development Co. Ltd. |
Procédé et trousses pour déterminer la sensibilité ou la résistance d'un cancer prostatique à une radiothérapie
|
WO2010097794A1
(fr)
|
2009-02-26 |
2010-09-02 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Procédés de reprogrammation de cellules rénales
|
SI3460062T1
(sl)
|
2009-03-02 |
2021-09-30 |
Evogene Ltd. |
Izolirani polinukleotidi in polipeptidi in postopki uporabe le-teh za zvišanje donosa in/ali poljedelskih značilnosti rastlin
|
ES2564265T3
(es)
|
2009-03-09 |
2016-03-21 |
Ramot At Tel-Aviv University Ltd. |
Composiciones para prevención y tratamiento de enfermedades neurodegenerativas
|
WO2010103517A1
(fr)
|
2009-03-12 |
2010-09-16 |
Rappaport Family Institute For Research In The Medical Sciences |
Compositions solubles pour le traitement de maladies associées aux ligands cxcr3
|
DK2414542T3
(da)
|
2009-03-30 |
2017-11-27 |
Tel Hashomer Medical Res Infrastructure & Services Ltd |
Fremgangsmåder til forudsigelse af klinisk forløb for og behandling af multipel sklerose
|
MX2011010401A
(es)
|
2009-04-01 |
2012-01-20 |
Rappaport Family Inst Res In The Medical Sciences |
Un metodo para regular la proliferacion y deferenciacion de queratinocitos.
|
WO2010116375A1
(fr)
|
2009-04-08 |
2010-10-14 |
Yeda Research And Development Co. Ltd. |
Peptides isolés pour réguler l'apoptose
|
DK2424896T3
(en)
|
2009-04-30 |
2015-12-14 |
Tel Hashomer Medical Res Infrastructure & Services Ltd |
The anti-CEACAM1 antibodies and methods of use thereof
|
EP2433136B1
(fr)
|
2009-05-19 |
2015-08-26 |
Zetiq Technologies Ltd. |
Kits et procédés pour coloration différentielle de cellules et/ou tissus cancéreux du col de l'utérus
|
WO2010137013A1
(fr)
|
2009-05-27 |
2010-12-02 |
Ramot At Tel Aviv University Ltd. |
Unités cristallisées de photosystème i dérivées du pois et leur utilisation dans des dispositifs solides
|
WO2010137021A2
(fr)
|
2009-05-27 |
2010-12-02 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Procédé de génération de tissu conjonctif
|
US20120083477A1
(en)
|
2009-05-27 |
2012-04-05 |
Yeda Research And Development Co. Ltd. |
Proteasome inhibitors and uses thereof
|
WO2010137020A1
(fr)
|
2009-05-28 |
2010-12-02 |
Yeda Research And Development Co. Ltd. |
Méthodes de traitement d'inflammation
|
US9096865B2
(en)
|
2009-06-10 |
2015-08-04 |
Evogene Ltd. |
Isolated polynucleotides and polypeptides, and methods of using same for increasing nitrogen use efficiency, yield, growth rate, vigor, biomass, oil content, and/or abiotic stress tolerance
|
US20120129183A1
(en)
|
2009-06-24 |
2012-05-24 |
Rappaport Family Institute For Research In The Medical Sciences |
Methods and kits for isolating placental derived microparticles and use of same for diagnosis of fetal disorders
|
US9663778B2
(en)
|
2009-07-09 |
2017-05-30 |
OPKO Biologies Ltd. |
Long-acting coagulation factors and methods of producing same
|
WO2011004379A1
(fr)
|
2009-07-10 |
2011-01-13 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Compositions et méthodes de traitement du cancer
|
CA2768725A1
(fr)
|
2009-07-21 |
2011-01-27 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Methode de diagnostic du cancer
|
GB0913442D0
(en)
|
2009-07-31 |
2009-09-16 |
Univ Ramot |
Cell-targeting nanoparticles comprising polynucleotide agents and uses thereof
|
WO2011021194A2
(fr)
|
2009-08-17 |
2011-02-24 |
Technion Research & Development Foundation Ltd. |
Cellules progénitrices de péricyte et leurs procédés de génération et d'utilisation
|
CA2770276A1
(fr)
|
2009-08-21 |
2012-02-24 |
Beeologics, Inc. |
Prevention et traitement de maladies des insectes benefiques par l'intermediaire de molecules transcrites vegetales
|
EP2470218A4
(fr)
*
|
2009-08-21 |
2013-04-03 |
Gilead Biologics Inc |
Procédés et compositions destinés au traitement de troubles fibrogènes pulmonaires
|
US20110207144A1
(en)
*
|
2009-08-21 |
2011-08-25 |
Derek Marshall |
In vitro screening assays
|
WO2011022670A1
(fr)
*
|
2009-08-21 |
2011-02-24 |
Arresto Biosciences, Inc |
Essais de criblage in vivo
|
AU2010284001A1
(en)
*
|
2009-08-21 |
2012-03-22 |
Gilead Biologics, Inc. |
Therapeutic methods and compositions
|
RU2012110585A
(ru)
*
|
2009-08-21 |
2013-09-27 |
Джилид Байолоджикс, Инк. |
Каталичические домены лизилоксидазы и loxl2
|
CN102596179A
(zh)
|
2009-08-27 |
2012-07-18 |
工业研究与发展基金会有限公司 |
脂质体组合物及其用途
|
US9610331B2
(en)
|
2009-09-08 |
2017-04-04 |
Yeda Research And Development Co. Ltd. |
Methods for hematopoietic precursor mobilization
|
WO2011030336A1
(fr)
|
2009-09-08 |
2011-03-17 |
Ramot At Tel-Aviv University Ltd. |
Procédés de diagnostic de la sclérose latérale amyotrophique (sla)
|
US20120171213A1
(en)
|
2009-09-10 |
2012-07-05 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Method of treating tumors
|
WO2011033506A2
(fr)
|
2009-09-17 |
2011-03-24 |
Yeda Research And Development Co. Ltd. |
Polypeptides pon1 isolés, polynucléotides codant pour ceux-ci et utilisations de ceux-ci dans le traitement ou la prévention des dommages associés à l'exposition à un organophosphate
|
US8212001B2
(en)
|
2009-09-17 |
2012-07-03 |
Ramot At Tel-Aviv University Ltd. |
Peptides for the treatment of oxidative stress related disorders
|
US8735124B2
(en)
|
2009-09-17 |
2014-05-27 |
Yeda Research And Development Co. Ltd. |
Isolated PON1 polypeptides, polynucleotides encoding same and uses thereof in treating or preventing organophosphate exposure associated damage
|
US20110081706A1
(en)
*
|
2009-10-02 |
2011-04-07 |
TransAlgae Ltd |
Method and system for efficient harvesting of microalgae and cyanobacteria
|
US8962584B2
(en)
|
2009-10-14 |
2015-02-24 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem, Ltd. |
Compositions for controlling Varroa mites in bees
|
CN105368836A
(zh)
|
2009-10-14 |
2016-03-02 |
耶路撒冷希伯来大学伊森姆研究发展公司 |
用于控制蜂中的瓦螨的组合物
|
CA2777663A1
(fr)
|
2009-10-16 |
2011-04-21 |
University Of Medicine And Dentistry Of New Jersey |
Procede de traitement d'une lesion chronique du tissu nerveux a l'aide d'une strategie de therapie de cellules
|
US9476060B2
(en)
|
2009-10-21 |
2016-10-25 |
Danziger Innovations Ltd. |
Generating genotypic variations in plant genomes by gamete infection
|
IL201999A
(en)
|
2009-11-08 |
2017-10-31 |
Medical Res & Development Fund For Health Services Bnai Zion Medical Center The State Of Israel |
A knockout mouse of the 1 – mo gene, a gene associated with morbidly extreme obesity
|
US20110143378A1
(en)
*
|
2009-11-12 |
2011-06-16 |
CyVek LLC. |
Microfluidic method and apparatus for high performance biological assays
|
ES2779048T3
(es)
|
2009-11-12 |
2020-08-13 |
Technion Res & Dev Foundation |
Medios de cultivo, cultivos celulares y métodos de cultivo de células madre pluripotentes en un estado indiferenciado
|
WO2011058555A1
(fr)
|
2009-11-12 |
2011-05-19 |
Yeda Research And Development Co. Ltd. |
Procédé d'édition de l'adn dans une cellule et constructions ayant cette capacité
|
US8962561B2
(en)
|
2009-11-12 |
2015-02-24 |
Ramot At Tel-Aviv University Ltd. |
Compositions comprising PEDF and uses of same in the treatment and prevention of ovary-related syndromes
|
WO2011061736A1
(fr)
|
2009-11-17 |
2011-05-26 |
Protalix Ltd. |
Alpha galactosidase alcaline pour le traitement de la maladie de fabry
|
US9216412B2
(en)
|
2009-11-23 |
2015-12-22 |
Cyvek, Inc. |
Microfluidic devices and methods of manufacture and use
|
US9759718B2
(en)
|
2009-11-23 |
2017-09-12 |
Cyvek, Inc. |
PDMS membrane-confined nucleic acid and antibody/antigen-functionalized microlength tube capture elements, and systems employing them, and methods of their use
|
US9651568B2
(en)
|
2009-11-23 |
2017-05-16 |
Cyvek, Inc. |
Methods and systems for epi-fluorescent monitoring and scanning for microfluidic assays
|
US9229001B2
(en)
|
2009-11-23 |
2016-01-05 |
Cyvek, Inc. |
Method and apparatus for performing assays
|
US9700889B2
(en)
|
2009-11-23 |
2017-07-11 |
Cyvek, Inc. |
Methods and systems for manufacture of microarray assay systems, conducting microfluidic assays, and monitoring and scanning to obtain microfluidic assay results
|
US10065403B2
(en)
|
2009-11-23 |
2018-09-04 |
Cyvek, Inc. |
Microfluidic assay assemblies and methods of manufacture
|
US9855735B2
(en)
|
2009-11-23 |
2018-01-02 |
Cyvek, Inc. |
Portable microfluidic assay devices and methods of manufacture and use
|
US9500645B2
(en)
|
2009-11-23 |
2016-11-22 |
Cyvek, Inc. |
Micro-tube particles for microfluidic assays and methods of manufacture
|
EP2504472A1
(fr)
|
2009-11-24 |
2012-10-03 |
Collplant Ltd. |
Procédé de production de fibres de collagène
|
CN105112357B
(zh)
|
2009-11-30 |
2020-10-23 |
普拉里斯坦有限公司 |
来源于胎盘的贴壁细胞及其在疾病治疗中的应用
|
US9562235B2
(en)
|
2009-12-06 |
2017-02-07 |
A.B. Seeds Ltd. |
MicroRNA compositions and methods for enhancing plant resistance to abiotic stress
|
EP2862929B1
(fr)
|
2009-12-09 |
2017-09-06 |
Quark Pharmaceuticals, Inc. |
Compositions et procédés pour le traitement de maladies, troubles ou lésions du système nerveux central
|
US9493785B2
(en)
|
2009-12-28 |
2016-11-15 |
Evogene Ltd. |
Isolated polynucleotides and polypeptides and methods of using same for increasing plant yield, biomass, growth rate, vigor, oil content, abiotic stress tolerance of plants and nitrogen use efficiency
|
US20130011376A1
(en)
|
2009-12-29 |
2013-01-10 |
Gamida Cell Ltd. |
Methods for Enhancing Natural Killer Cell Proliferation and Activity
|
KR101754437B1
(ko)
|
2010-01-05 |
2017-07-05 |
바스큘라 바이오제닉스 리미티드 |
특이적 항-혈관형성 아데노바이러스제의 사용방법
|
JP6009357B2
(ja)
|
2010-01-12 |
2016-10-19 |
バスキュラー バイオジェニックス リミテッド |
アデノウイルスベクターの生産方法およびそれによって生成されるウイルス調製物
|
EA201270701A1
(ru)
|
2010-01-27 |
2013-01-30 |
Йеда Рисеч Энд Девелопмент Ко. Лтд. |
Ингибирующие металлопротеины антитела
|
AU2011212830B2
(en)
|
2010-02-04 |
2014-05-22 |
Gilead Biologics, Inc. |
Antibodies that bind to lysyl oxidase-like 2 (LOXL2) and methods of use therefor
|
WO2011099006A2
(fr)
|
2010-02-11 |
2011-08-18 |
Yeda Research And Development Co. Ltd. |
Systèmes enzymatiques pour la fixation du carbone et procédés de production associés
|
WO2011104708A2
(fr)
|
2010-02-24 |
2011-09-01 |
Ben Gurion University Of The Negev Research And Development Authority |
Méthodes d'inhibition de la nécrose
|
WO2011107939A1
(fr)
|
2010-03-01 |
2011-09-09 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Méthodes de prédiction de l'efficacité d'un traitement par anti-vegfa pour des tumeurs solides
|
WO2011107994A1
(fr)
|
2010-03-04 |
2011-09-09 |
Yeda Research And Development Co. Ltd. |
Procédés de mesure de la stabilité d'une protéine
|
WO2011111034A1
(fr)
|
2010-03-08 |
2011-09-15 |
Yeda Research And Development Co. Ltd. |
Production de protéines recombinantes dans des systèmes hétérologues
|
MX2012010479A
(es)
|
2010-03-08 |
2012-10-09 |
Monsanto Technology Llc |
Moleculas polinucleotidicas para regulacion genetica en plantas.
|
CN102918159A
(zh)
|
2010-03-11 |
2013-02-06 |
雅各布·埃德尔 |
产生氢的方法
|
EP2556085A2
(fr)
|
2010-04-05 |
2013-02-13 |
Bar-Ilan University |
Polypeptides formant des pores pouvant être activés par une protéase
|
EP2557913B1
(fr)
|
2010-04-12 |
2016-08-03 |
Ben Gurion University Of The Negev Research And Development Authority |
Sulfotransférase d'une microalgue rouge et utilisations de celle-ci
|
US8927274B2
(en)
|
2010-04-12 |
2015-01-06 |
Technion Research & Development Foundation Limited |
Populations of pancreatic progenitor cells and methods of isolating and using same
|
WO2011132182A1
(fr)
|
2010-04-18 |
2011-10-27 |
Yeda Research And Development Co. Ltd. |
Molécules et méthodes d'utilisation de celles-ci pour le traitement des maladies associées aux ligands erbb/erbb
|
AU2011246876B2
(en)
|
2010-04-28 |
2016-06-23 |
Evogene Ltd. |
Isolated polynucleotides and polypeptides, and methods of using same for increasing plant yield and/or agricultural characteristics
|
US20130053277A1
(en)
|
2010-05-04 |
2013-02-28 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Methods of identifying inhibitors of polypeptides-of-interest
|
US9352000B2
(en)
|
2010-05-05 |
2016-05-31 |
Rappaport Family Institute For Research In The Medical Sciences |
Use of CCL1 in therapy
|
IL208820A0
(en)
|
2010-10-19 |
2011-01-31 |
Rachel Teitelbaum |
Biologic female contraceptives
|
PL2569417T3
(pl)
|
2010-05-13 |
2018-12-31 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Izolowane populacje dorosłych komórek nerkowych i sposoby ich izolowania i stosowania
|
EP2575859B1
(fr)
|
2010-06-03 |
2018-09-19 |
Ramot at Tel Aviv University, Ltd. |
Méthodes pour le traitement du diabéte et compositions aptes à ce traitement
|
MX2012014284A
(es)
|
2010-06-07 |
2013-04-29 |
Osnat Ashur-Fabian |
Metodos y kits para diagnosticar afecciones relacionadas con hipoxia.
|
WO2011158243A2
(fr)
|
2010-06-16 |
2011-12-22 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Procédé de diagnostic et de traitement du cancer
|
WO2011158242A2
(fr)
|
2010-06-16 |
2011-12-22 |
Futuragene Israel Ltd. |
Plantes résistantes aux organismes nuisibles
|
US9512188B2
(en)
|
2010-07-12 |
2016-12-06 |
The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization (Aro) (Volcani Center) |
Isolated polynucleotides and methods and plants using same for regulating plant acidity
|
US9695410B2
(en)
|
2010-07-15 |
2017-07-04 |
Technion Research & Development Foundation Limited |
Isolated high affinity entities with T-cell receptor like specificity towards native complexes of MHC class II and glutamic acid decarboxylase (GAD) autoantigenic peptides
|
WO2012007950A2
(fr)
|
2010-07-15 |
2012-01-19 |
Technion Research & Development Foundation Ltd. |
Entités de haute affinité isolées présentant une spécificité de type récepteur des lymphocytes t pour les complexes natifs du mhc de classe ii et les peptides auto-antigéniques associés au diabète
|
EP2593554A2
(fr)
|
2010-07-15 |
2013-05-22 |
Technion Research And Development Foundation Ltd. |
Construction d'acide nucléique destinée à accroître la tolérance au stress abiotique dans des végétaux
|
US9624469B2
(en)
|
2010-07-22 |
2017-04-18 |
Cellect Biotherapeutics Ltd. |
Regulatory immune cells with enhanced targeted cell death effect
|
US9144585B2
(en)
|
2010-07-27 |
2015-09-29 |
Technion Research & Development Foundation Limited |
Isolated mesenchymal progenitor cells and extracellular matrix produced thereby
|
US20130130311A1
(en)
|
2010-07-27 |
2013-05-23 |
Yeda Research And Development Co., Ltd. |
Methods and systems for assessing clonality of cell cultures
|
JP2013535966A
(ja)
|
2010-07-27 |
2013-09-19 |
テクニオン リサーチ アンド ディベロップメント ファウンデーション リミテッド |
引き抜かれた毛包由来のケラチン生成細胞から誘導多能性幹細胞を生成させる方法
|
US8901074B2
(en)
|
2010-08-04 |
2014-12-02 |
Ramot At Tel-Aviv University |
Methods of treating autoimmune diseases of the central nervous system (CNS) and neurodegenerative diseases
|
EP2606165B1
(fr)
|
2010-08-16 |
2016-10-12 |
Sinai Health System |
Marqueurs du tractus urogénital mâle
|
SG187830A1
(en)
|
2010-08-22 |
2013-03-28 |
Univ Ramot |
Induced pluripotent stem cells derived from human pancreatic beta cells
|
WO2012025925A1
(fr)
|
2010-08-24 |
2012-03-01 |
Rappaport Family Institute For Research In The Medical Sciences |
Procédés d'amélioration de la transplantation en utilisant des sdf-1alpha
|
WO2012028993A2
(fr)
|
2010-08-30 |
2012-03-08 |
Evogene Ltd. |
Polynucléotides et polypeptides isolés, et procédés les utilisant pour augmenter l'efficacité d'utilisation de l'azote, le rendement, la vitesse de croissance, la vigueur, la biomasse, la teneur d'huile, et/ou la tolérance aux stress abiotiques
|
WO2012032510A1
(fr)
|
2010-09-07 |
2012-03-15 |
Yeda Research And Development Co. Ltd. |
Amorces pour l'amplification d'adn et procédés de sélection de ces dernières
|
SG188411A1
(en)
|
2010-09-07 |
2013-04-30 |
Technion Res & Dev Foundation |
Novel methods and culture media for culturing pluripotent stem cells
|
WO2012032519A2
(fr)
|
2010-09-07 |
2012-03-15 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Méthodes de diagnostic de la maladie de parkinson
|
US20130164288A1
(en)
|
2010-09-07 |
2013-06-27 |
Protalix Ltd. |
Readthrough acetylcholinesterase (ache-r) for treating or preventing parkinson's disease
|
KR20130105652A
(ko)
|
2010-09-08 |
2013-09-25 |
예다 리서치 앤드 디벨럽먼트 캄파니 리미티드 |
안정하고 장기간의 인그래프트먼트를 위한 면역억제 약물의 조합
|
CA2810632C
(fr)
|
2010-09-08 |
2020-06-02 |
Yeda Research And Development Co. Ltd. |
Utilisation de lymphocytes t de memoire centrale anti-tiers dans le traitement contre la leucemie et le lymphome
|
WO2012035539A1
(fr)
|
2010-09-15 |
2012-03-22 |
Ramot At Tel-Aviv University Ltd. |
Procédés d'expansion et de redifférenciation de cellules bêta des îlots
|
WO2012038956A1
(fr)
|
2010-09-20 |
2012-03-29 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Procédé de traitement de maladies neurodégénératives
|
EP2627766B1
(fr)
|
2010-10-17 |
2016-05-25 |
Yeda Research and Development Co. Ltd. |
Procédés et compositions utilisables en vue du traitement de pathologies médicales associées à l'insuline
|
WO2012052878A1
(fr)
|
2010-10-19 |
2012-04-26 |
Vascular Biogenics Ltd. |
Polynucléotides isolés et constructions d'acide nucléique pour diriger l'expression d'un gène d'intérêt dans des cellules
|
WO2012056452A2
(fr)
|
2010-10-27 |
2012-05-03 |
Nanocyte (Israel) Ltd. |
Compositions pharmaceutiques et dispositifs d'administration comprenant des cellules ou capsules urticantes
|
US10066024B2
(en)
|
2010-10-28 |
2018-09-04 |
Yeda Research And Development Co. Ltd. |
Methods of generating antibodies to metalloenzymes
|
CA2815927A1
(fr)
|
2010-11-03 |
2012-05-10 |
Yissum Research Development Company Of The Hebrew University Of Jerusale M Ltd. |
Plantes transgeniques a rendements de saccharification ameliores, et procede pour les generer
|
WO2012059925A2
(fr)
|
2010-11-04 |
2012-05-10 |
Ben-Gurion University Of The Negev Research And Development Authority |
Acyl-coa: gène de type diacylglycérol acyltransférase 1 (ptdgat1) et utilisations de celui-ci
|
MX2013005413A
(es)
|
2010-11-15 |
2014-02-27 |
Univ Ramot |
Analogos de dipeptidos para el tratamiento de afecciones asociadas con la formacion de fibrillas amiloides.
|
WO2012066495A2
(fr)
|
2010-11-17 |
2012-05-24 |
Ben Gurion University Of The Negev Research And Development Authority |
Thérapie à base de cellules t pour les maladies neurodégénératives
|
EP2646543A4
(fr)
|
2010-12-02 |
2014-09-03 |
Technion Res & Dev Foundation |
Procédé de génération de cellules cornéennes et populations de cellules les comprenant
|
EP2463382A1
(fr)
|
2010-12-07 |
2012-06-13 |
Enterologics, Inc. |
Procédé d'identification de E. Coli M-17
|
EP2652125B1
(fr)
|
2010-12-15 |
2017-04-26 |
Kadimastem Ltd. |
Cellules produisant de l'insuline dérivées de cellules souches pluripotentes
|
CA2821257C
(fr)
|
2010-12-22 |
2020-12-22 |
Evogene Ltd. |
Polynucleotides et polypeptides isoles, et procedes d'utilisation de ceux-ci pour augmenter la tolerance vis-a-vis du stress abiotique, le rendement, le taux de croissance, la vigueur, la biomasse, la teneur en huile et/ou l'efficacite d'utilisation d'azote de plantes
|
KR101947126B1
(ko)
|
2010-12-28 |
2019-02-13 |
카메디스 리미티드 |
감염의 치료 및 예방을 위한 식물 추출물
|
SI3272861T1
(sl)
|
2011-01-20 |
2020-06-30 |
Protalix Ltd. |
Alfa-galaktozidazni sestavki
|
WO2012104851A1
(fr)
|
2011-01-31 |
2012-08-09 |
Yeda Research And Development Co. Ltd. |
Méthodes de diagnostic d'une maladie utilisant une pcr d'extension-chevauchement
|
WO2012114339A1
(fr)
|
2011-02-23 |
2012-08-30 |
Rappaport Family Institute For Research In The Medical Sciences |
Molécules de haute affinité capables de se lier à un récepteur plexine de type a et leurs utilisations
|
CN103597078B
(zh)
|
2011-03-02 |
2016-12-14 |
富途锐基尼以色列有限公司 |
具有功能失调的t3ss蛋白的抗菌性转基因植物
|
WO2012117373A1
(fr)
|
2011-03-03 |
2012-09-07 |
Ramot At Tel-Aviv University Ltd. |
Cellules musculaires génétiquement modifiées qui expriment des facteurs neurotrophiques
|
SG192632A1
(en)
|
2011-03-06 |
2013-09-30 |
Merck Serono Sa |
Low fucose cell lines and uses thereof
|
WO2012120518A1
(fr)
|
2011-03-08 |
2012-09-13 |
Ramot At Tel-Aviv University Ltd. |
Compositions et méthodes de diagnostic et de traitement de phénylcétonurie (pcu)
|
US20140086839A1
(en)
|
2011-03-17 |
2014-03-27 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Quinolone analogs for treating autoimmune diseases
|
WO2012123949A1
(fr)
|
2011-03-17 |
2012-09-20 |
Ramot At Tel-Aviv University Ltd. |
Anticorps asymétriques bi- et monospécifiques et leur procédé de génération
|
EP3260533B1
(fr)
|
2011-03-22 |
2019-09-11 |
Pluristem Ltd. |
Les méthodes de traitement des rayonnements ou des blessures causées par des produits chimiques
|
CN103648517B
(zh)
|
2011-03-24 |
2016-04-20 |
纽瑞姆制药(1991)有限公司 |
神经保护肽
|
WO2012131680A2
(fr)
|
2011-03-28 |
2012-10-04 |
Yeda Research And Development Co. Ltd. |
Compositions et procédés pour le traitement de l'inflammation
|
WO2012137202A1
(fr)
|
2011-04-05 |
2012-10-11 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Composition comprenant un indicateur de fer attaché à une microparticule et utilisations de celle-ci pour quantifier du fer non lié à la transferrine (ntbi) et du fer labile cellulaire (lci)
|
AU2012240953B2
(en)
|
2011-04-06 |
2017-02-23 |
Ramot At Tel-Aviv University Ltd. |
Methods of monitoring and analyzing metabolic activity profiles diagnostic and therapeutic uses of same
|
US9150644B2
(en)
|
2011-04-12 |
2015-10-06 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Human monoclonal antibodies that bind insulin-like growth factor (IGF) I and II
|
WO2012140519A2
(fr)
|
2011-04-15 |
2012-10-18 |
Pluristem Ltd. |
Procédés et systèmes de récolte de cellules
|
MX354195B
(es)
|
2011-05-03 |
2018-02-16 |
Evogene Ltd |
Polipeptidos y polinucleotidos aislados y metodos para su uso, para aumentar el rendimiento, la biomasa, el indice de crecimiento, el vigor, el contenido de aceite, la tolerancia al estrés abiotico de las plantas y la eficiencia en el uso de nitrogeno.
|
US9192670B2
(en)
|
2011-05-04 |
2015-11-24 |
Ramot At Tel-Aviv University Ltd. |
Regulation of amyloid beta molecular composition for the treatment of alzheimer's disease
|
WO2012153333A1
(fr)
|
2011-05-09 |
2012-11-15 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Régénération et réparation de tissu mésenchymateux par utilisation d'amélogénine
|
WO2012153336A2
(fr)
|
2011-05-12 |
2012-11-15 |
Rakuto Bio Technologies Ltd. |
Procédés et dispositifs pour éclaircir la carnation de la peau
|
WO2012156976A1
(fr)
|
2011-05-16 |
2012-11-22 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Procédés de préparation d'artémisinine dans des plantes non-hôtes et vecteurs destinés à une utilisation dans celles-ci
|
US20140088017A1
(en)
|
2011-05-23 |
2014-03-27 |
Yeda Research And Development Co., Ltd. |
Use of akt phosphorylation as a biomarker for prognosing neurodegenerative diseases and treating same
|
WO2012160526A2
(fr)
|
2011-05-23 |
2012-11-29 |
Ofir Menashe |
Formulations à base de particules contenant des micro-organismes et leurs utilisations
|
CN104039812A
(zh)
|
2011-05-31 |
2014-09-10 |
和黄生物膜医疗解决方案有限公司 |
细胞聚集体的分散和脱离
|
WO2012164565A1
(fr)
|
2011-06-01 |
2012-12-06 |
Yeda Research And Development Co. Ltd. |
Compositions et procédés pour la régulation à la baisse de gènes procaryotes
|
US10166295B2
(en)
|
2011-06-02 |
2019-01-01 |
Opko Biologics Ltd. |
Pegylated OXM variants
|
KR102014554B1
(ko)
|
2011-06-02 |
2019-08-26 |
다이액스 코포레이션 |
Fc 수용체 결합 단백질
|
US9415103B2
(en)
|
2011-06-14 |
2016-08-16 |
Yeda Research And Development Co. Ltd. |
Combination therapy to prevent DCIS formation and progression to breast cancer
|
MX2014000180A
(es)
|
2011-06-23 |
2014-03-27 |
Kaiima Bio Agritech Ltd |
Trigo comun, sus plantas o partes que tienen un genoma parcial o completamente multiplicado, sus hibridos y productos y metodos para generarlos y utilizarlos.
|
AR087220A1
(es)
|
2011-07-20 |
2014-02-26 |
Kaiima Bio Agritech Ltd |
Plantas de maiz que tienen un genoma parcial o completamente multiplicado y sus usos
|
US20130030452A1
(en)
|
2011-07-27 |
2013-01-31 |
Health Corporation - Rambam |
Devices for surgical applications
|
WO2013018060A2
(fr)
|
2011-08-04 |
2013-02-07 |
Yeda Research And Development Co. Ltd. |
Micro-arn et compositions les comprenant pour le traitement et le diagnostic de troubles médicaux associés à la sérotonine, à l'adrénaline, à la noradrénaline, au glutamate et à l'hormone de libération de la corticotropine
|
EP2741753A2
(fr)
|
2011-08-09 |
2014-06-18 |
Yeda Research and Development Co. Ltd. |
Régulation à la baisse de mir-7 pour favoriser la différenciation des cellules bêta et la production d'insuline
|
EP2741602A1
(fr)
|
2011-08-14 |
2014-06-18 |
Kaiima Bio Agritech Ltd. |
Plantes de blé dur ayant un génome partiellement ou complètement multiplié, et leurs utilisations
|
WO2013035070A1
(fr)
|
2011-09-07 |
2013-03-14 |
Yeda Research And Development Co. Ltd. |
Signature olfactive et mélange odorant la contenant
|
JP6196620B2
(ja)
|
2011-09-08 |
2017-09-13 |
イェダ リサーチ アンド デベロップメント カンパニー リミテッド |
抗第三者セントラルメモリーt細胞、その作製方法ならびに移植および疾患処置におけるその使用
|
ES2657552T3
(es)
|
2011-09-08 |
2018-03-05 |
Yeda Research And Development Co. Ltd. |
Nuevos biomarcadores de riesgo para el cáncer de pulmón
|
US10806146B2
(en)
|
2011-09-13 |
2020-10-20 |
Monsanto Technology Llc |
Methods and compositions for weed control
|
US10829828B2
(en)
|
2011-09-13 |
2020-11-10 |
Monsanto Technology Llc |
Methods and compositions for weed control
|
US10760086B2
(en)
|
2011-09-13 |
2020-09-01 |
Monsanto Technology Llc |
Methods and compositions for weed control
|
UA116090C2
(uk)
|
2011-09-13 |
2018-02-12 |
Монсанто Текнолоджи Ллс |
Спосіб та композиція для боротьби з бур'янами (варіанти)
|
WO2013040057A1
(fr)
|
2011-09-13 |
2013-03-21 |
Monsanto Technology Llc |
Procédés et compositions de lutte contre les mauvaises herbes
|
US9416363B2
(en)
|
2011-09-13 |
2016-08-16 |
Monsanto Technology Llc |
Methods and compositions for weed control
|
PL2755467T3
(pl)
|
2011-09-13 |
2018-01-31 |
Monsanto Technology Llc |
Sposoby i kompozycje do kontroli chwastów
|
WO2013054320A1
(fr)
|
2011-10-11 |
2013-04-18 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Anticorps dirigés contre la molécule d'adhésion cellulaire associée à l'antigène carcino-embryonnaire (ceacam)
|
AU2012325604B2
(en)
|
2011-10-21 |
2017-08-03 |
Augurex Life Sciences Corp. |
Antigens derived from citrullinated 14-3-3 and uses thereof in the diagnosis of rheumatoid arthritis
|
EP2771464B1
(fr)
|
2011-10-27 |
2018-03-21 |
Yeda Research and Development Co. Ltd. |
Procédés de traitement du cancer
|
SG11201401648RA
(en)
|
2011-11-03 |
2014-05-29 |
Quark Pharmaceuticals Inc |
Methods and compositions for neuroprotection
|
US20140323549A1
(en)
|
2011-11-08 |
2014-10-30 |
Quark Pharmaceuticals, Inc. |
Methods and compositions for treating diseases, disorders or injury of the nervous system
|
US9736998B2
(en)
|
2011-11-23 |
2017-08-22 |
Danziger Dan Flower Farm |
Otomeria plants
|
WO2013076730A1
(fr)
|
2011-11-27 |
2013-05-30 |
Yeda Research And Development Co. Ltd. |
Méthodes de régulation de l'angiogenèse et compositions capables de réguler l'angiogenèse
|
EP2788009B1
(fr)
|
2011-12-08 |
2016-05-25 |
Yeda Research and Development Co. Ltd. |
Cellules pulmonaires fétales de mammifères et leur utilisation thérapeutique
|
WO2013093921A1
(fr)
|
2011-12-20 |
2013-06-27 |
Collplant Ltd. |
Fibres de polymère synthétique enrobées de collagène
|
BR112014015959A8
(pt)
|
2011-12-22 |
2017-07-04 |
Yeda Res & Dev |
método para o tratamento de um indivíduo em necessidade de um enxerto de célula não singênico ou tecido, método para tratar um indivíduo que precisa de um transplante de célula hematopoiética imatura, método para induzir a tolerância específica do doador em um indivíduo que precisa de uma célula não singênica ou enxerto de tecido, e método para tratar um indivíduo que precisa de uma célula não singênica ou enxerto de tecido
|
US20130164193A1
(en)
|
2011-12-22 |
2013-06-27 |
Life Technologies Corporation |
Sequential lateral flow capillary device for analyte determination
|
MX2014008083A
(es)
|
2011-12-28 |
2015-03-19 |
Kaiima Bio Agritech Ltd |
Una planta de sorgo cultivada que tiene un genoma parcial o totalmente multiplicado y usos de la misma.
|
US20150216998A1
(en)
|
2012-01-01 |
2015-08-06 |
Ramot At Tel-Aviv University Ltd. |
Endo180-targeted particles for selective delivery of therapeutic and diagnostic agents
|
WO2013114363A2
(fr)
|
2012-01-30 |
2013-08-08 |
Yeda Research And Development Co.Ltd. |
Agents antimicrobiens
|
EP2809780B1
(fr)
|
2012-02-01 |
2018-05-02 |
Protalix Ltd. |
Composition liquide inhalable de dnase i
|
WO2013118120A2
(fr)
|
2012-02-06 |
2013-08-15 |
Rosetta Green Ltd. |
Polynucléotides isolés exprimant ou modulant des microarn ou des cibles de ceux-ci, plantes transgéniques comprenant ceux-ci et leurs utilisations dans l'amélioration de l'efficacité d'utilisation de l'azote, de la tolérance au stress abiotique, de la biomasse, de la vigueur ou du rendement d'une plante
|
JP6348848B2
(ja)
|
2012-02-13 |
2018-06-27 |
ガミダ セル リミテッド |
間葉系幹細胞の増殖
|
KR102118729B1
(ko)
|
2012-02-14 |
2020-06-05 |
옵코 바이오로직스 리미티드 |
장기 작용 응고 인자들 및 이를 생산하는 방법들
|
KR20140130495A
(ko)
|
2012-02-19 |
2014-11-10 |
프로탈릭스 리미티드 |
고셰병 치료용 경구형 단위 투약 형태 및 이의 용도
|
WO2013124816A2
(fr)
|
2012-02-22 |
2013-08-29 |
Brainstem Biotec Ltd. |
Génération de cellules souches neuronales et de motoneurones
|
WO2013124817A2
(fr)
|
2012-02-22 |
2013-08-29 |
Brainstem Biotec Ltd. |
Microarn pour la génération d'astrocytes
|
WO2013128454A1
(fr)
|
2012-03-01 |
2013-09-06 |
The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization, (A.R.O.), Volcani Center |
Plantes d'ail stérile mâle, descendance hybride de celles-ci et procédés de génération et d'utilisation de celles-ci
|
EP2822971B1
(fr)
|
2012-03-07 |
2018-07-18 |
Yeda Research and Development Co. Ltd. |
Compositions inhibitrices de la quiescine sulfhydryle oxydase (qsox1) et leurs utilisations
|
KR102114734B1
(ko)
|
2012-03-08 |
2020-05-25 |
싸이벡, 아이엔씨 |
미세유체 분석 장치용 마이크로튜브 입자 및 제조방법
|
EP2828280B1
(fr)
|
2012-03-22 |
2018-05-02 |
Ramot at Tel-Aviv University Ltd. |
Peptides multimères plif et utilisations de ceux-ci
|
IN2014MN01886A
(fr)
|
2012-04-18 |
2015-07-10 |
Univ Ramot |
|
PE20142405A1
(es)
|
2012-04-19 |
2015-01-25 |
Opko Biolog Ltd |
Variantes de oxintomodulina de accion prolongada y metodos de produccion de las mismas
|
EP2841084B1
(fr)
|
2012-04-24 |
2018-05-30 |
Biokine Therapeutics Ltd. |
Peptide antagoniste de cxcr4 et son utilisation pour le traitment de tumeurs pulmonaires
|
EP2846819B1
(fr)
|
2012-05-09 |
2017-05-03 |
Yeda Research and Development Co. Ltd. |
Variants de pro-domaine tace en tant qu'inhibiteur de tnf-a et leur utilisation médicale
|
US10240161B2
(en)
|
2012-05-24 |
2019-03-26 |
A.B. Seeds Ltd. |
Compositions and methods for silencing gene expression
|
KR101937733B1
(ko)
|
2012-05-24 |
2019-01-11 |
마운트게이트 그룹 리미티드 |
광견병 감염의 방지 및 치료에 관한 조성물 및 방법
|
WO2013183048A1
(fr)
|
2012-06-03 |
2013-12-12 |
Ben-Gurion University Of The Negev Research And Development Authority |
Peptides de liaison au titane fonctionnalisés et implants revêtus par ceux-ci
|
MX362432B
(es)
|
2012-06-04 |
2019-01-17 |
Opko Biologics Ltd |
Variantes de oxm pegilada.
|
EP2870110A1
(fr)
|
2012-07-03 |
2015-05-13 |
Nanospun Technologies Ltd. |
Procédés et dispositifs pour l'adsorption et la biodégradation de pétrole
|
US9175266B2
(en)
|
2012-07-23 |
2015-11-03 |
Gamida Cell Ltd. |
Enhancement of natural killer (NK) cell proliferation and activity
|
US9567569B2
(en)
|
2012-07-23 |
2017-02-14 |
Gamida Cell Ltd. |
Methods of culturing and expanding mesenchymal stem cells
|
EP3594331A1
(fr)
|
2012-07-29 |
2020-01-15 |
Yeda Research and Development Co. Ltd. |
Utilisation de la voie de la glycine réductrice en vue de la génération de microorganismes formatotrophes et autotrophes
|
WO2014020608A1
(fr)
|
2012-07-31 |
2014-02-06 |
Yeda Research And Development Co. Ltd. |
Procédés de diagnostic et de traitement de maladies du neurone moteur
|
CA2877223C
(fr)
|
2012-08-06 |
2019-08-27 |
Brainstorm Cell Therapeutics Ltd. |
Procedes de generation de cellules souches mesechymateuses qui secretent des facteurs neurotrophiques
|
AR092868A1
(es)
|
2012-09-03 |
2015-05-06 |
A B Seeds Ltd |
Metodo para mejorar la tolerancia al estres abiotico de plantas y plantas generadas mediante dicho metodo
|
US10543278B2
(en)
|
2012-09-12 |
2020-01-28 |
Ramot At Tel-Aviv University Ltd. |
Immunoparticles and methods of generating and using same
|
US11105809B2
(en)
|
2012-10-09 |
2021-08-31 |
Ramot At Tel-Aviv University Ltd. |
Methods and kits for predicting prognosis of cancer using soluble mortalin in blood
|
CN104918639B
(zh)
|
2012-10-22 |
2018-01-26 |
萨拜格Rfa公司 |
用于将治疗剂递送到活细胞和细胞核中的系统
|
US20150266970A1
(en)
|
2012-10-24 |
2015-09-24 |
Yeda Research And Development Co. Ltd. |
Combinations of epidermal growth factor receptor targeting antibodies for treating cancer
|
EP2912181B1
(fr)
|
2012-10-29 |
2017-11-29 |
Yeda Research and Development Co., Ltd. |
Aptamères, aptamères multimères et leurs utilisations
|
BR122020018510B1
(pt)
|
2012-11-20 |
2023-03-14 |
Opko Biologics Ltd |
Método para aumentar incrementalmente o tamanho hidrodinâmico de um fator de coagulação ativado viia
|
CA2877847A1
(fr)
|
2012-11-29 |
2014-06-05 |
Yeda Research And Development Co. Ltd. |
Methodes de prevention d'une metastase tumorale, de traitement et de pronostic du cancer, et d'identification d'agents susceptibles de constituer des inhibiteurs de metastase
|
AU2013371825B2
(en)
|
2013-01-01 |
2019-10-24 |
A.B. Seeds Ltd. |
Methods of introducing dsRNA to plant seeds for modulating gene expression
|
US10683505B2
(en)
|
2013-01-01 |
2020-06-16 |
Monsanto Technology Llc |
Methods of introducing dsRNA to plant seeds for modulating gene expression
|
WO2014108850A2
(fr)
|
2013-01-09 |
2014-07-17 |
Yeda Research And Development Co. Ltd. |
Analyse de transcriptome à haut débit
|
WO2014108854A1
(fr)
|
2013-01-09 |
2014-07-17 |
Fusimab Ltd. |
Anticorps anti-hgf et anti-ang2 monospécifiques, et anticorps anti-hgf/anti-ang2 bispécifiques
|
WO2014111936A1
(fr)
|
2013-01-17 |
2014-07-24 |
Novellusdx Ltd. |
Procédés et systèmes pour identifier des mutations conductrices spécifiques à un patient
|
WO2014118785A1
(fr)
|
2013-02-04 |
2014-08-07 |
Ramot At Tel-Aviv University Ltd. |
Génération de lignées cellulaires spécifiques d'une tumeur cytotoxiques et leurs utilisations
|
EP2964669B1
(fr)
|
2013-03-06 |
2018-09-12 |
Protalix Ltd. |
Utilisation de cellules végétales exprimant un inhibiteur du polypeptide tnf alpha en thérapie
|
US20160017020A1
(en)
|
2013-03-06 |
2016-01-21 |
Protalix Ltd. |
Chimeric polypeptides, polynucleotides encoding same, cells expressing same and methods of producing same
|
UA123082C2
(uk)
|
2013-03-13 |
2021-02-17 |
Монсанто Текнолоджи Ллс |
Спосіб та гербіцидна композиція для боротьби з видами рослин роду sorghum
|
AR095233A1
(es)
|
2013-03-13 |
2015-09-30 |
Monsanto Technology Llc |
Métodos y composiciones para el control de malezas
|
US10568328B2
(en)
|
2013-03-15 |
2020-02-25 |
Monsanto Technology Llc |
Methods and compositions for weed control
|
EP2976097B1
(fr)
|
2013-03-21 |
2021-05-26 |
CollPlant Ltd. |
Compositions comprenant du collagène et prp pour la régénération tissulaire et leurs procédés de production
|
AU2014240733B2
(en)
|
2013-03-24 |
2018-11-22 |
Biolinerx Ltd. |
Methods of treating myeloid leukemia
|
BR112015026702A2
(pt)
|
2013-04-21 |
2018-02-06 |
Yeda Res And Developmente Co Ltd |
métodos de extermínio de células senescentes
|
WO2014174470A1
(fr)
|
2013-04-23 |
2014-10-30 |
Yeda Research And Development Co. Ltd. |
Cellules souches pluripotentes naïves isolées et leurs procédés de génération
|
EP2989119B1
(fr)
|
2013-04-25 |
2018-03-21 |
Yeda Research and Development Co., Ltd. |
Utilisation de peptides inhibiteurs pour le traitement de maladies inflammatoires
|
WO2014188423A1
(fr)
|
2013-05-21 |
2014-11-27 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Traitement de pathologies associées aux mastocytes
|
EP3626310A1
(fr)
|
2013-05-27 |
2020-03-25 |
Rakuto Bio Technologies Ltd. |
Système enzymatique contenant des compositions cosmétiques
|
WO2014207744A1
(fr)
|
2013-06-24 |
2014-12-31 |
Ramot At Tel-Aviv University Ltd. |
Échafaudage à base d'épiploon et système d'administration
|
US9850496B2
(en)
|
2013-07-19 |
2017-12-26 |
Monsanto Technology Llc |
Compositions and methods for controlling Leptinotarsa
|
CA2918387C
(fr)
|
2013-07-19 |
2021-11-02 |
Monsanto Technology Llc |
Compositions et methodes de lutte contre leptinotarsa
|
WO2015015489A1
(fr)
|
2013-07-30 |
2015-02-05 |
Biolinerx Ltd. |
Anticorps convenant au traitement du diabète et de maladies autoimmunes
|
EP3039030B1
(fr)
|
2013-08-29 |
2018-09-19 |
Yeda Research and Development Co. Ltd. |
Inhibiteurs sélectifs de l'isoforme alpha2 de la na,k-atpase et leur utilisation pour réduire la pression intra-oculaire
|
IL228284A
(en)
|
2013-09-03 |
2016-12-29 |
Technion Res & Dev Foundation |
Implants from cellular scaffolding and blood vessel stalk
|
WO2015033343A1
(fr)
|
2013-09-03 |
2015-03-12 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Compositions et procédés utilisables en vue de l'expression de polypeptides recombinés
|
WO2015033344A1
(fr)
|
2013-09-05 |
2015-03-12 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Procédés et nécessaires permettant d'inhiber la pathogénicité d'un streptocoque du groupe a (sga) ou d'un streptocoque du groupe g (sgg)
|
WO2015037009A1
(fr)
|
2013-09-16 |
2015-03-19 |
Plexicure Ltd. |
Protéines isolées capables de se lier à la plexine-a4, et procédés de production et d'utilisation
|
WO2015040609A1
(fr)
|
2013-09-17 |
2015-03-26 |
Yeda Research And Development Co. Ltd. |
Nouveaux peptides d'erk et leurs utilisations
|
EP3052191B1
(fr)
|
2013-10-01 |
2020-03-18 |
Kadimastem Ltd. |
Différenciation dirigée d'astrocytes à partir de cellules souches pluripotentes humaines pour utilisation dans le criblage de médicaments et le traitement de la sclérose latérale amyotrophique (sla)
|
EP3763733A1
(fr)
|
2013-10-21 |
2021-01-13 |
OPKO Biologics Ltd. |
Polypeptides à action prolongée et procédés de production et d'administration associés
|
US20150158926A1
(en)
|
2013-10-21 |
2015-06-11 |
Opko Biologics, Ltd. |
Long-acting polypeptides and methods of producing and administering same
|
EP3060656A1
(fr)
|
2013-10-24 |
2016-08-31 |
Yeda Research and Development Co., Ltd. |
Polynucléotides codant pour des polypeptides de système brex et leurs méthodes d'utilisation
|
US20160243187A1
(en)
|
2013-10-31 |
2016-08-25 |
Biokine Therapeutics Ltd. |
Methods of treating acute myeloid leukemia with a flt3 mutation
|
NZ719544A
(en)
|
2013-11-04 |
2022-09-30 |
Beeologics Inc |
Compositions and methods for controlling arthropod parasite and pest infestations
|
EP3074391B1
(fr)
|
2013-11-28 |
2019-07-31 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Inhibiteurs de l'arn polymérase i et leurs utilisations
|
EP3074044A2
(fr)
|
2013-11-28 |
2016-10-05 |
Yeda Research and Development Co., Ltd. |
Inhibiteurs de synaptojanine-2 et leurs utilisations
|
UA119253C2
(uk)
|
2013-12-10 |
2019-05-27 |
Біолоджикс, Інк. |
Спосіб боротьби із вірусом у кліща varroa та у бджіл
|
ES2697757T3
(es)
|
2013-12-10 |
2019-01-28 |
Yeda Res & Dev |
Uso de enzimas que catalizan la síntesis de piruvato a partir de formiato y acetil-CoA y bacterias que expresan la misma
|
WO2015108982A2
(fr)
|
2014-01-15 |
2015-07-23 |
Monsanto Technology Llc |
Procédés et compositions pour la lutte contre les mauvaises herbes utilisant des polynucléotides epsps
|
US20160340659A1
(en)
|
2014-01-30 |
2016-11-24 |
Yissum Research And Development Company Of The Hebrew University Of Jerusalem Ltd. |
Actin binding peptides and compositions comprising same for inhibiting angiogenesis and treating medical conditions associated with same
|
CN106470699A
(zh)
|
2014-02-03 |
2017-03-01 |
耶路撒冷希伯来大学的益生研究开发有限公司 |
使用酪蛋白激酶i抑制剂以消耗干细胞的用途
|
CN111733231A
(zh)
|
2014-02-05 |
2020-10-02 |
耶达研究及发展有限公司 |
用于治疗和诊断的微rna和包含所述微rna的组合物
|
EP3102607B1
(fr)
|
2014-02-06 |
2018-08-22 |
Yeda Research and Development Co. Ltd. |
Anticorps anti cd84, compositions les comprenant et leurs utilisations
|
WO2015118547A1
(fr)
|
2014-02-10 |
2015-08-13 |
Protalix Ltd. |
Méthode de maintien de la stabilité d'une maladie chez un sujet atteint de la maladie de gaucher
|
JP6628253B2
(ja)
|
2014-02-11 |
2020-01-08 |
ブレインストーム セル セラペウティクス リミテッド |
細胞の適性を判定する方法
|
WO2015132784A1
(fr)
|
2014-03-03 |
2015-09-11 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Procédé et dispositif de détection de pseudomonas aeruginosa
|
EP2923709A1
(fr)
|
2014-03-28 |
2015-09-30 |
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. |
Vaccin contre la malaria multi-composants-multi-étapes
|
EP3420809A1
(fr)
|
2014-04-01 |
2019-01-02 |
Monsanto Technology LLC |
Compositions et procédés pour lutter contre les insectes nuisibles
|
WO2015155777A1
(fr)
|
2014-04-10 |
2015-10-15 |
Bonus Therapeutics Ltd. |
Compositions pour la réparation des os
|
DK4026917T3
(da)
|
2014-04-14 |
2024-02-12 |
Yissum Research And Development Company Of The Hebrew Univ Of Jerusalem Ltd |
Fremgangsmåde og kit til bestemmelse af cellers eller vævs død eller dna's vævs- eller celleoprindelse ved dna-methyleringsanalyse
|
ES2764504T3
(es)
|
2014-04-17 |
2020-06-03 |
Yeda Res & Dev |
Métodos y equipos para analizar restos de unión al ADN fijados al ADN
|
EA037613B1
(ru)
|
2014-04-27 |
2021-04-21 |
Фэймуэйв Лтд. |
Гуманизированные антитела против ceacam1
|
US11427647B2
(en)
|
2014-04-27 |
2022-08-30 |
Famewave Ltd. |
Polynucleotides encoding humanized antibodies against CEACAM1
|
CN106460048B
(zh)
|
2014-04-28 |
2021-01-05 |
耶达研究及发展有限公司 |
针对试剂的微生物组应答
|
US20170191065A1
(en)
|
2014-05-04 |
2017-07-06 |
Forrest Innovations Ltd. |
Compositions and methods of using same for increasing resistance of infected mosquitoes
|
EP3145947A2
(fr)
|
2014-05-22 |
2017-03-29 |
Yeda Research and Development Co., Ltd. |
Micro-organismes recombinés pouvant fixer le carbone
|
US20170253881A1
(en)
|
2014-06-02 |
2017-09-07 |
Technion Research & Development Foundation Limited |
Compositions and methods of selectively inhibiting irp1 and treating inflammation
|
WO2015186128A1
(fr)
|
2014-06-02 |
2015-12-10 |
Kadimastem Ltd. |
Procédés d'induction de la myélinisation et de maturation des oligodendrocytes
|
CN106795515B
(zh)
|
2014-06-23 |
2021-06-08 |
孟山都技术公司 |
用于经由rna干扰调控基因表达的组合物和方法
|
US20170183376A1
(en)
|
2014-06-24 |
2017-06-29 |
Insight Biopharmaceuticals Ltd. |
Methods of purifying antibodies
|
EP3161138A4
(fr)
|
2014-06-25 |
2017-12-06 |
Monsanto Technology LLC |
Procédés et compositions pour administrer des acides nucléiques à des cellules végétales et réguler l'expression génique
|
JP6587288B2
(ja)
|
2014-06-25 |
2019-10-09 |
テル ハショマー メディカル リサーチ インフラストラクチャー アンド サーヴィシーズ リミテッド |
がん幹細胞の同定ならびに診断および処置のためのその使用
|
JP2017520549A
(ja)
|
2014-06-26 |
2017-07-27 |
ラモット アット テル アビブ ユニバーシティ, リミテッド |
核酸の送達のためのリポソーム製剤
|
WO2016005985A2
(fr)
|
2014-07-09 |
2016-01-14 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Méthode pour reprogrammer des cellules
|
KR102569494B1
(ko)
|
2014-07-15 |
2023-08-21 |
이슘 리서치 디벨롭먼트 컴퍼니 오브 더 히브루 유니버시티 오브 예루살렘 엘티디. |
Cd44의 단리된 폴리펩타이드 및 이의 사용
|
WO2016013007A1
(fr)
|
2014-07-21 |
2016-01-28 |
Novellusdx Ltd. |
Procédés de détermination d'une réponse à un médicament de mutations spécifiques à un patient
|
US11015229B2
(en)
|
2014-07-21 |
2021-05-25 |
Novellusdx Ltd. |
Methods and systems for determining oncogenic index of patient specific mutations
|
WO2016018887A1
(fr)
|
2014-07-29 |
2016-02-04 |
Monsanto Technology Llc |
Compositions et méthodes pour lutter contre les insectes nuisibles
|
CN108064274A
(zh)
|
2014-07-30 |
2018-05-22 |
耶达研究及发展有限公司 |
用于培养多能干细胞的培养基
|
CA2954601C
(fr)
|
2014-08-14 |
2023-04-18 |
Memed Diagnostics Ltd. |
Analyse computationnelle de donnees biologiques au moyen d'un collecteur et d'un hyperplan
|
WO2016030899A1
(fr)
|
2014-08-28 |
2016-03-03 |
Yeda Research And Development Co. Ltd. |
Méthodes de traitement de la sclérose latérale amyotrophique
|
EP2992895A1
(fr)
|
2014-09-08 |
2016-03-09 |
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. |
Vaccin contre la malaria multi-composants-multi-étapes
|
US10526416B2
(en)
|
2014-09-08 |
2020-01-07 |
Yeda Research And Development Co. Ltd. |
Anti-HER3 antibodies and uses of same
|
AU2015313811A1
(en)
|
2014-09-08 |
2017-04-06 |
Yeda Research And Development Co. Ltd. |
Compositions and methods for treating cancer resistant to a tyrosine kinase inhibitor (TKI)
|
IL234638A0
(en)
|
2014-09-14 |
2014-12-02 |
Yeda Res & Dev |
NMDA receptor antagonists for the treatment of Gaucher disease
|
US10174320B2
(en)
|
2014-09-21 |
2019-01-08 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Downregulating miR-132 for the treatment of lipid related disorders
|
GB2536745B
(en)
|
2014-10-20 |
2019-06-26 |
Gen Probe Inc |
Red Blood cell lysis solution
|
ES2965744T3
(es)
|
2014-11-13 |
2024-04-16 |
Enzootic Holdings Ltd |
Inversión sexual funcional de crustáceos decápodos hembras
|
EP3220945A2
(fr)
|
2014-11-17 |
2017-09-27 |
Yeda Research and Development Co., Ltd. |
Procédés de traitement de maladies associées à une fonction mitochondriale
|
JP2017533723A
(ja)
|
2014-11-17 |
2017-11-16 |
イェダ リサーチ アンド ディベロップメント カンパニー リミテッドYeda Research And Development Co.Ltd. |
マイクロバイオーム解析方法
|
EA038931B9
(ru)
|
2014-11-20 |
2022-02-18 |
Йиссум Рисерч Дивелопмент Компани Оф Зе Хебрю Юниверсити Оф Иерусалим Лтд. |
Композиции и способы получения полипептидов с модифицированным профилем гликозилирования в клетках растений
|
WO2016084088A1
(fr)
|
2014-11-26 |
2016-06-02 |
Ramot At Tel-Aviv University Ltd. |
Élimination ciblée de gènes bactériens
|
EP3224363B1
(fr)
|
2014-11-27 |
2021-11-03 |
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. |
Construction d'acide nucléique pour l'édition de génome
|
WO2016092555A2
(fr)
|
2014-12-11 |
2016-06-16 |
Yeda Research And Development Co. Ltd. |
Polypeptides de phosphotriestérase isolés, polynucléotides codant pour ceux-ci et utilisations de ceux-ci dans le traitement ou la prévention des dommages associés à l'exposition aux organophosphates
|
WO2016103269A1
(fr)
|
2014-12-23 |
2016-06-30 |
Ramot At Tel-Aviv University Ltd. |
Populations de cellules progénitrices neuronales et leurs procédés de production et d'utilisation
|
IL305070A
(en)
|
2014-12-30 |
2023-10-01 |
Cell Cure Neurosciences Ltd |
RPE cell populations and methods for their production
|
BR112017014332A2
(pt)
|
2014-12-30 |
2018-01-02 |
Cell Cure Neurosciences Ltd |
métodos de tratamento de doenças retinianas
|
JP2018502575A
(ja)
|
2014-12-30 |
2018-02-01 |
セル キュア ニューロサイエンシズ リミテッド |
網膜色素上皮細胞集団の評価法
|
CN107406837A
(zh)
|
2015-01-04 |
2017-11-28 |
波塔力克斯有限公司 |
修饰的dna酶及其用途
|
WO2016116935A1
(fr)
|
2015-01-21 |
2016-07-28 |
Yeda Research And Development Co. Ltd. |
Utilisation de la rasa2 en tant que marqueur pronostique et thérapeutique pour un mélanome
|
US10968449B2
(en)
|
2015-01-22 |
2021-04-06 |
Monsanto Technology Llc |
Compositions and methods for controlling Leptinotarsa
|
WO2016135732A1
(fr)
|
2015-02-26 |
2016-09-01 |
Yeda Research And Development Co. Ltd. |
Procédé favorisant la pousse des cheveux
|
WO2016142948A1
(fr)
|
2015-03-11 |
2016-09-15 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Oligonucléotides leurres pour le traitement de maladies
|
IL237852A0
(en)
|
2015-03-19 |
2016-03-24 |
Yeda Res & Dev |
Antibodies against amphigoline, medical preparations containing them and their use
|
EP3273971A4
(fr)
|
2015-03-27 |
2018-12-05 |
Yeda Research and Development Co. Ltd. |
Méthodes de traitement des maladies des motoneureones
|
JP2018518152A
(ja)
|
2015-03-27 |
2018-07-12 |
ユニバーシティ オブ サザン カリフォルニア |
充実性腫瘍を処置するためのlhrに指向されたcar t細胞治療
|
CA2979309A1
(fr)
|
2015-03-31 |
2016-10-06 |
Yeda Research And Development Co. Ltd. |
Glutamate oxaloacetate transaminase 1 (got1), preparations, procedes de generation des preparations et utilisations des preparations
|
EP3277260B1
(fr)
|
2015-04-01 |
2021-05-12 |
The State of Israel, Ministry of Agriculture & Rural Development, Agricultural Research Organization (ARO) (Volcani Center) |
Extraits végétaux de crassifolium erodium l'her et leurs utilisations
|
KR20180002676A
(ko)
|
2015-04-07 |
2018-01-08 |
엘라 파마 리미티드 |
Cathepsin c 및/또는 cela1 및/또는 cela3a 및/또는 그와 관련된 구조적 효소를 타겟으로 하여 세포 또는 조직의 감염을 치료 및/또는 예방하기위한 조성물
|
EP3081575A1
(fr)
|
2015-04-12 |
2016-10-19 |
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. |
Anticorps anti-plasmodium pour parasite
|
CA2986202C
(fr)
|
2015-04-27 |
2023-08-22 |
The Medical Research, Infrastructure and Health Services Fund of the Tel Aviv Medical Center |
Molecules de ciblage egr1 dans le traitement de maladies inflammatoires et hyperproliferatives
|
EP3288386B1
(fr)
|
2015-04-29 |
2022-01-19 |
The State of Israel, Ministry of Agriculture & Rural Development, Agricultural Research Organization (ARO) (Volcani Center) |
Compositions anti-phytopathogènes
|
WO2016174652A1
(fr)
|
2015-04-30 |
2016-11-03 |
Technion Research & Development Foundation Limited |
Récepteurs antigéniques chimériques et méthodes d'utilisation correspondantes
|
CN108026566A
(zh)
|
2015-05-04 |
2018-05-11 |
特拉维夫大学拉莫特有限公司 |
用于使dna片段化的方法和试剂盒
|
WO2016181393A1
(fr)
|
2015-05-11 |
2016-11-17 |
Yeda Research And Development Co. Ltd. |
Inhibiteurs de citrine pour le traitement du cancer
|
EP3298141A4
(fr)
|
2015-05-17 |
2019-01-09 |
The Medical Research, Infrastructure, And Health Services Fund Of The Tel Aviv Medical Center |
Compositions et méthodes de traitement du cancer
|
WO2016185457A1
(fr)
|
2015-05-19 |
2016-11-24 |
Yeda Research And Development Co. Ltd. |
Méthodes pour favoriser la lymphagiogenèse
|
US10849985B2
(en)
|
2015-05-20 |
2020-12-01 |
Yeda Research And Development Co. Ltd. |
Method of targeting senescent cells
|
EP3297727A1
(fr)
|
2015-05-21 |
2018-03-28 |
Yeda Research and Development Co. Ltd |
Populations bactériennes pour favoriser la santé
|
KR20180014754A
(ko)
|
2015-05-29 |
2018-02-09 |
옵코 바이오로직스 리미티드 |
페길화된 옥신토모둘린 변이체
|
UY36703A
(es)
|
2015-06-02 |
2016-12-30 |
Monsanto Technology Llc |
Composiciones y métodos para la administración de un polinucleótido en una planta
|
AU2016270913A1
(en)
|
2015-06-03 |
2018-01-04 |
Monsanto Technology Llc |
Methods and compositions for introducing nucleic acids into plants
|
JP7010473B2
(ja)
|
2015-06-04 |
2022-02-10 |
ユニバーシティ オブ サザン カリフォルニア |
Lym-1およびlym-2標的化car細胞免疫療法
|
NL2014935B1
(en)
|
2015-06-08 |
2017-02-03 |
Applied Immune Tech Ltd |
T cell receptor like antibodies having fine specificity.
|
WO2016203476A1
(fr)
|
2015-06-18 |
2016-12-22 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Procédés et compositions pour le diagnostic et le traitement d'un cancer urothélial
|
EP4026563A1
(fr)
|
2015-06-18 |
2022-07-13 |
Yeda Research and Development Co. Ltd |
Protocoles de conditionnement et utilisation de ceux-ci pour la régénération de tissu
|
WO2016203482A2
(fr)
|
2015-06-19 |
2016-12-22 |
Opko Biologics Ltd. |
Facteurs de coagulation à action prolongée et leurs procédés de production
|
KR20210089270A
(ko)
|
2015-07-16 |
2021-07-15 |
바이오카인 테라퓨틱스 리미티드 |
암 치료용 조성물 및 방법
|
JP7057748B2
(ja)
|
2015-07-16 |
2022-04-20 |
イェダ リサーチ アンド ディベロップメント カンパニー リミテッド |
遺伝子改変された抗第三者中枢性メモリーt細胞および免疫療法におけるその使用
|
EP3325494B1
(fr)
|
2015-07-19 |
2020-12-30 |
Yeda Research and Development Co., Ltd. |
Inhibiteurs séléctifs de na,k-atpase contenant des isoformes alpha2 et leur utilisation pour réduire la pression intraoculaire
|
EP3324754B1
(fr)
|
2015-07-22 |
2022-09-07 |
Phytopharma International Ltd. |
Compositions consommables par les abeilles, procédés d'utilisation de ces compositions pour la production de miel, et miel produit par ces procédés
|
EP3862425A1
(fr)
|
2015-07-29 |
2021-08-11 |
Hadasit Medical Research Services and Development Ltd. |
Production à grande échelle de cellules épithéliales pigmentaires rétiniennes
|
US20180221393A1
(en)
|
2015-08-03 |
2018-08-09 |
Biokine Therapeutics Ltd. |
Cxcr4 binding agents for treatment of diseases
|
WO2017021961A1
(fr)
|
2015-08-04 |
2017-02-09 |
Yeda Research And Development Co. Ltd. |
Procédés de criblage pour riborégulateurs et atténuateurs
|
AU2016303632B2
(en)
|
2015-08-05 |
2022-09-29 |
Cell Cure Neurosciences Ltd. |
Preparation of retinal pigment epithelium cells
|
CA2993910A1
(fr)
|
2015-08-05 |
2017-02-09 |
Cell Cure Neurosciences Ltd. |
Preparation de photorecepteurs pour le traitement de maladies retiniennes
|
WO2017025963A1
(fr)
|
2015-08-10 |
2017-02-16 |
The Medical Research, Infrastructure and Health Services Fund of the Tel Aviv Medical Center |
Méthodes et compositions pharmaceutiques permettant d'améliorer la cicatrisation des plaies par cd24
|
EP3334831A1
(fr)
|
2015-08-13 |
2018-06-20 |
Forrest Innovations Ltd. |
Formulations et compositions d'administration d'acides nucléiques à des cellules végétales
|
WO2017033188A1
(fr)
|
2015-08-24 |
2017-03-02 |
Yeda Research And Development Co. Ltd. |
Huile et biocarburant d'origine algale et leurs procédés de production
|
US10765706B2
(en)
|
2015-09-03 |
2020-09-08 |
University Of South Florida |
Method of stem cell delivery into the brain during chronic disease using blood brain barrier permeabilizers
|
WO2017042816A1
(fr)
|
2015-09-10 |
2017-03-16 |
Yeda Research And Development Co. Ltd. |
Ablation de cellules dendritiques dont le test est positif pour la perforine, dans le traitement du cancer
|
EP3365376A1
(fr)
|
2015-10-25 |
2018-08-29 |
Yeda Research and Development Co., Ltd. |
Anticorps ciblant la quiescine sulfhydryle oxydase (qsox1) et leurs utilisations
|
US20180312805A1
(en)
|
2015-10-26 |
2018-11-01 |
Cell Cure Neurosciences Ltd. |
Preparation of Retinal Pigment Epithelium Cells
|
CA3187317A1
(fr)
|
2015-10-27 |
2017-05-04 |
Jay Pharma, Inc. |
Compositions comprenant du cannabidiol et un des seconds agents therapeutiques pour le traitement du cancer
|
IL242380A0
(en)
|
2015-10-29 |
2016-02-01 |
Yeda Res & Dev |
A method for inducing the division of cardiomyocytes and treating heart diseases
|
WO2017077539A1
(fr)
|
2015-11-03 |
2017-05-11 |
Ariel-University Research And Development Company Ltd. |
Compositions destinées à la régénération et à la réparation de tissu nerveux
|
US20180327855A1
(en)
|
2015-11-11 |
2018-11-15 |
Ramot At Tel-Aviv University Ltd. |
Methods of detecting 5-hydroxymethylcytosine and diagnosing of cancer
|
US11679133B2
(en)
|
2015-11-30 |
2023-06-20 |
Kadimastem Ltd. |
Methods for differentiating and purifying pancreatic endocrine cells
|
US10228367B2
(en)
|
2015-12-01 |
2019-03-12 |
ProteinSimple |
Segmented multi-use automated assay cartridge
|
EP3176183A1
(fr)
|
2015-12-02 |
2017-06-07 |
Yeda Research and Development Co. Ltd |
Compositions et procédés pour traiter un cancer non résistant à un inhibiteur de la tyrosine kinase (tki)
|
ES2924732T3
(es)
|
2015-12-16 |
2022-10-10 |
Univ Ramot |
Partículas que comprenden epiplón descelularizado
|
EP3397344A4
(fr)
|
2015-12-28 |
2019-08-28 |
B.G. Negev Technologies and Applications Ltd. at Ben-Gurion University |
Composition et méthode pour le traitement de la sclérose latérale amyotrophique
|
JP2019505511A
(ja)
|
2016-01-06 |
2019-02-28 |
イェダ リサーチ アンド ディベロップメント カンパニー リミテッドYeda Research And Development Co.Ltd. |
悪性疾患、自己免疫疾患および炎症性疾患を処置するための組成物および方法
|
US20190178888A1
(en)
|
2016-01-11 |
2019-06-13 |
Technion Research & Development Foundation Limited |
Methods of determining prognosis of sepsis and treating same
|
WO2017125931A1
(fr)
|
2016-01-21 |
2017-07-27 |
The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization (Aro) (Volcani Center) |
Plantes parthénocarpiques et procédés de production de celles-ci
|
IL243838A
(en)
|
2016-01-28 |
2017-07-31 |
Sp Nano Ltd |
The composition containing sp1 protein and carbon nanoparticles and its uses
|
IL243839B
(en)
|
2016-01-28 |
2018-01-31 |
Sp Nano Ltd |
Conductive wires
|
WO2017130205A1
(fr)
|
2016-01-31 |
2017-08-03 |
Hadasit Medical Research Services And Development Ltd. |
Populations de cellules souches pluripotentes ayant une composition de chromosomes sexuels non identiques et leurs utilisations
|
JP7072508B2
(ja)
|
2016-02-04 |
2022-05-20 |
イェダ リサーチ アンド ディベロップメント カンパニー リミテッド |
変異型p53と関連している疾患、障害または病状の処置におけるペプチドおよびその使用
|
US20190142875A1
(en)
|
2016-02-14 |
2019-05-16 |
Yeda Research And Development Co. Ltd. |
Microbiome-based diagnosis, prediction and treatment of relapsing obesity
|
US20190046497A1
(en)
|
2016-02-14 |
2019-02-14 |
Yeda Research And Development Co., Ltd. |
Methods of modulating protein exocytosis and uses of same in therapy
|
KR20180111987A
(ko)
|
2016-02-16 |
2018-10-11 |
이슘 리서치 디벨롭먼트 컴퍼니 오브 더 히브루 유니버시티 오브 예루살렘 엘티디. |
시아노박테리아 및 식물 성장 억제용 비-단백질 페닐알라닌 유사체
|
WO2017145162A1
(fr)
|
2016-02-23 |
2017-08-31 |
Chaya Brodie |
Production de cellules souches cancéreuses et leur utilisation
|
KR20180133399A
(ko)
|
2016-03-01 |
2018-12-14 |
이섬 리서치 디벨러프먼트 컴파니 오브 더 히브루 유니버시티 오브 예루살렘 엘티디. |
인간 폴리오바이러스 수용체(pvr)에 특이적인 항체
|
EP3907292A1
(fr)
|
2016-03-03 |
2021-11-10 |
Memed Diagnostics Ltd. |
Analyse d'arn pour diagnostiquer un type d'infection
|
US20190216891A1
(en)
|
2016-03-06 |
2019-07-18 |
Yeda Research And Development Co., Ltd. |
Method for modulating myelination
|
IL244649A0
(en)
|
2016-03-17 |
2016-06-30 |
Yeda Res & Dev |
Methods for the isolation of barrel-like proteases and the identification of peptides that are cleaved by Alidan
|
US10421785B2
(en)
|
2016-04-11 |
2019-09-24 |
Bar-Ilan University |
Delta receptor agonist peptides and use thereof
|
CA3021914A1
(fr)
|
2016-04-27 |
2017-11-02 |
Gen-Probe Incorporated |
Reactif de lyse de cellules sanguines
|
WO2017203520A1
(fr)
|
2016-05-22 |
2017-11-30 |
Yeda Research And Development Co. Ltd. |
Méthodes d'utilisation de cellules pulmonaires pour transplantation et induction de tolérance
|
IL245861A0
(en)
|
2016-05-25 |
2016-09-04 |
Yeda Res & Dev |
Use of substances to treat drug-resistant tumors
|
WO2017208247A1
(fr)
|
2016-06-02 |
2017-12-07 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Essai pour l'élimination de résidus de méthyle-cytosine de l'adn
|
EP3464322B1
(fr)
|
2016-06-05 |
2023-04-05 |
Tel HaShomer Medical Research Infrastructure and Services Ltd. |
Nouvelles molécules destinées au traitement de l'inflammation
|
US20190160152A1
(en)
|
2016-06-09 |
2019-05-30 |
Opko Biologics Ltd. |
Long-acting oxyntomodulin formulation and methods of producing and administering same
|
US11859232B2
(en)
|
2016-06-19 |
2024-01-02 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Screening for chemotherapy resistance in human haploid cells
|
WO2018002924A1
(fr)
|
2016-06-27 |
2018-01-04 |
Yeda Research And Development Co. Ltd. |
Cellules veto générées à partir de lymphocytes t mémoire
|
WO2018011795A1
(fr)
|
2016-07-10 |
2018-01-18 |
Memed Diagnostics Ltd. |
Signatures de protéines permettant d'établir la différence entre des infections bactériennes et des infections virales
|
EP3482201B1
(fr)
|
2016-07-10 |
2022-12-14 |
Memed Diagnostics Ltd. |
Diagnostic précoce d'infections
|
IL246722A0
(en)
|
2016-07-11 |
2016-09-29 |
Yeda Res & Dev |
Combined treatment to increase endogenous synthesis of nitric oxide
|
CN109714962A
(zh)
|
2016-07-11 |
2019-05-03 |
耶路撒冷希伯来大学的益生研究开发有限公司 |
用于在体外培养细胞的系统和方法
|
WO2018011799A1
(fr)
|
2016-07-11 |
2018-01-18 |
Opko Biologics Ltd. |
Facteur vii de coagulation à action prolongée et procédés de production associés
|
WO2018011804A1
(fr)
|
2016-07-11 |
2018-01-18 |
Bonus Therapeutics Ltd. |
Compositions cellulaires pour la régénération tissulaire
|
US20190203270A1
(en)
|
2016-07-24 |
2019-07-04 |
Yeda Research And Development Co., Ltd. |
Methods and kits for analyzing dna binding moieties attached to dna
|
ES2965761T3
(es)
|
2016-08-08 |
2024-04-16 |
Tech Innovation Momentum Fund Israel Limited Partnership |
Sistemas bacterianos para el análisis de polipéptidos ubiquitilados
|
EP3504553B1
(fr)
|
2016-08-10 |
2022-04-20 |
Memed Diagnostics Ltd. |
Système et procédé d'analyse de données biologiques
|
CN109843305B
(zh)
|
2016-08-14 |
2023-03-10 |
雷蒙特亚特特拉维夫大学有限公司 |
治疗神经障碍的间充质细胞来源的外泌体
|
IL247368A0
(en)
|
2016-08-18 |
2016-11-30 |
Yeda Res & Dev |
Diagnostic and therapeutic uses of exosomes
|
WO2018037416A1
(fr)
|
2016-08-25 |
2018-03-01 |
Yeda Research And Development Co. Ltd. |
Procédés et compositions pour le traitement de maladies auto-immunes
|
WO2018047154A1
(fr)
|
2016-09-07 |
2018-03-15 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Anticorps anti-nkp46 et leur utilisation thérapeutique
|
EP3512943B1
(fr)
|
2016-09-14 |
2023-04-12 |
Yeda Research and Development Co. Ltd. |
Crisp-seq, procédé intégré pour séquençage massivement parallèle d'arn unicellulaire et criblages regroupés par crispr
|
US11385241B2
(en)
|
2016-09-29 |
2022-07-12 |
Memed Diagnostics Ltd. |
Methods of prognosis and treatment
|
IL248468A0
(en)
|
2016-10-13 |
2017-01-31 |
Technion Res & Dev Foundation |
Use of caspase-3 inhibitors and caspase-3 activators in the preparation of medical preparations for cancer treatment and wound healing
|
IL248385A0
(en)
|
2016-10-18 |
2017-02-01 |
Yeda Res & Dev |
Treatment of circadian rhythm disorder
|
WO2018087759A1
(fr)
|
2016-11-10 |
2018-05-17 |
Yeda Research And Development Co. Ltd. |
Phosphotriestérases destinés au traitement ou à prévention des dommages associés à l'exposition aux organophosphates
|
US11542508B2
(en)
|
2016-11-28 |
2023-01-03 |
Yeda Research And Development Co. Ltd. |
Isolated polynucleotides and polypeptides and methods of using same for expressing an expression product of interest
|
EP3548015A1
(fr)
|
2016-11-30 |
2019-10-09 |
Yeda Research and Development Co. Ltd. |
Méthodes de traitement de maladies et de la toxicité hépathique
|
SG11201810936VA
(en)
|
2016-12-01 |
2019-01-30 |
Univ Ramot |
Combined treatment for nerve injuries
|
WO2018134824A1
(fr)
|
2017-01-18 |
2018-07-26 |
Yeda Research And Development Co. Ltd. |
Cellules veto génétiquement modifiées et leur utilisation en immunothérapie
|
IL250479A0
(en)
|
2017-02-06 |
2017-03-30 |
Sorek Rotem |
Genetically engineered cells expressing a disarm system that confers resistance to phages and methods for their production
|
IL250916A0
(en)
|
2017-03-02 |
2017-06-29 |
Geiger Benjamin |
Methods for growing t cells in culture and their use
|
WO2018167780A1
(fr)
|
2017-03-12 |
2018-09-20 |
Yeda Research And Development Co. Ltd. |
Méthodes de diagnostic et de traitement du cancer
|
US20200150125A1
(en)
|
2017-03-12 |
2020-05-14 |
Yeda Research And Development Co., Ltd. |
Methods of diagnosing and prognosing cancer
|
IL269363B2
(en)
|
2017-03-16 |
2024-02-01 |
Lineage Cell Therapeutics Inc |
Methods for measuring medical effects of treating retinal diseases
|
JP2020516243A
(ja)
|
2017-04-05 |
2020-06-11 |
イェダ リサーチ アンド ディベロップメント カンパニー リミテッドYeda Research And Development Co.Ltd. |
エクスビボ培養系およびその使用方法
|
IL252151A0
(en)
|
2017-05-07 |
2017-07-31 |
Fainzilber Michael |
Treatment of stress disorders
|
WO2018207184A2
(fr)
|
2017-05-10 |
2018-11-15 |
Ariel Scientific Innovations Ltd. |
Procédés de purification d'anticorps
|
WO2018216006A1
(fr)
|
2017-05-21 |
2018-11-29 |
The Medical Research, Infrastructure and Health Services Fund of the Tel Aviv Medical Center |
Combinaison de marqueurs pour diagnostiquer un cancer
|
EP3634991A1
(fr)
|
2017-05-23 |
2020-04-15 |
Technion Research & Development Foundation Limited |
Agents inhibant la dimérisation de gads et leurs procédés d'utilisation
|
WO2018220582A1
(fr)
|
2017-05-31 |
2018-12-06 |
Tropic Biosciences UK Limited |
Méthodes de sélection de cellules comprenant des événements d'édition de génome
|
GB201708665D0
(en)
|
2017-05-31 |
2017-07-12 |
Tropic Biosciences Uk Ltd |
Compositions and methods for increasing extractability of solids from coffee beans
|
GB201708662D0
(en)
|
2017-05-31 |
2017-07-12 |
Tropic Biosciences Uk Ltd |
Compositions and methods for increasing shelf-life of banana
|
WO2018229764A1
(fr)
|
2017-06-13 |
2018-12-20 |
Yeda Research And Development Co. Ltd. |
Traitement de la sclérose en plaques avancée ou progressive
|
EP3652344A1
(fr)
|
2017-07-13 |
2020-05-20 |
Yissum Research and Development Company of the Hebrew University of Jerusalem Ltd. |
Cibles d'adn à titre de marqueurs de méthylation spécifiques de tissu
|
EP3652342A1
(fr)
|
2017-07-13 |
2020-05-20 |
Yissum Research and Development Company of the Hebrew University of Jerusalem Ltd. |
Détection d'adn spécifique d'un tissu
|
US11466323B2
(en)
|
2017-07-13 |
2022-10-11 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Dual-probe digital droplet PCR strategy for specific detection of tissue-specific circulating DNA molecules
|
IL253642A0
(en)
|
2017-07-24 |
2017-09-28 |
Seger Rony |
Combined treatment for cancer
|
IL253984A0
(en)
|
2017-08-14 |
2017-09-28 |
Yeda Res & Dev |
Immunotherapy against aranviruses that bind through transferrin receptor 1 (tfr1
|
US11692166B2
(en)
|
2017-08-23 |
2023-07-04 |
Technion Research & Development Foundation Limited |
Compositions and methods for improving alcohol tolerance in yeast
|
EP3684930B1
(fr)
|
2017-09-19 |
2022-05-04 |
Tropic Biosciences UK Limited |
Modification de la spécificité de molécules d'arn non codantes végétales pour le silençage de l'expression génique
|
WO2019094595A2
(fr)
|
2017-11-09 |
2019-05-16 |
Pinteon Therapeutics Inc. |
Méthodes et compositions pour la génération et l'utilisation d'anticorps tau phosphorylés spécifiques à une conformation humanisée
|
IL255664A0
(en)
|
2017-11-14 |
2017-12-31 |
Shachar Idit |
Hematopoietic stem cells with enhanced properties
|
CA3083436A1
(fr)
|
2017-11-29 |
2019-06-06 |
Weedout Ltd. |
Compositions, kits et procedes de lutte contre les mauvaises herbes du genre amaranthus
|
US20200390800A1
(en)
|
2017-11-29 |
2020-12-17 |
Ramot At Tel-Aviv University Ltd. |
Methods of preventing or treating neurogenic shock
|
EP3716993A1
(fr)
|
2017-12-03 |
2020-10-07 |
Yeda Research and Development Co. Ltd |
Traitement d'une maladie cardiaque ischémique
|
EP3723785A1
(fr)
|
2017-12-17 |
2020-10-21 |
Yeda Research and Development Co. Ltd |
Modulateurs du complexe signalosome cop9 (csn) et leurs utilisations
|
EP3731965A1
(fr)
|
2017-12-28 |
2020-11-04 |
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. |
Procédé pour reproduire des rythmes circadiens sur une puce microfluidique
|
IL257225A
(en)
|
2018-01-29 |
2018-04-09 |
Yeda Res & Dev |
Treatment of sarcoma
|
IL257269A
(en)
|
2018-01-31 |
2018-04-09 |
Olender Tsviya |
Signaling is directed to the endoplasmic reticulum
|
EP3749368A1
(fr)
|
2018-02-08 |
2020-12-16 |
Yeda Research and Development Co. Ltd |
Procédés d'identification et d'utilisation d'agents pour traiter des maladies associées à un dysfonctionnement de la barrière intestinale
|
EP3749689A1
(fr)
|
2018-02-08 |
2020-12-16 |
Yeda Research and Development Co. Ltd |
Inhibiteurs du protéasome 20s
|
EP3755340A4
(fr)
|
2018-02-23 |
2021-11-17 |
Carmel-Haifa University Economic Corporation Ltd. |
Méthodes de traitement d'un trouble de la mémoire et d'un dysfonctionnement cognitif
|
US20200408761A1
(en)
|
2018-02-28 |
2020-12-31 |
The Medical Research, Infrastructure and Health Services Fund of the Tel Aviv Medical Center |
Methods of diagnosing and treating bladder cancer
|
EP3765034A1
(fr)
|
2018-03-12 |
2021-01-20 |
Yeda Research and Development Co. Ltd |
Traitement d'une maladie cardiaque
|
EP3774047A1
(fr)
|
2018-03-29 |
2021-02-17 |
Yeda Research and Development Co. Ltd |
Utilisation de gradients de champ électrique pour commander l'expression génique
|
EP3773506A4
(fr)
|
2018-03-29 |
2021-12-22 |
Technion Research & Development Foundation Limited |
Vésicules comprenant un inhibiteur de pten et leurs utilisations
|
IL258467A
(en)
|
2018-03-29 |
2018-07-04 |
Ilana Kolodkin Gal |
Methods of disrupting a biofilm and/or preventing formation of same
|
GB201807192D0
(en)
|
2018-05-01 |
2018-06-13 |
Tropic Biosciences Uk Ltd |
Compositions and methods for reducing caffeine content in coffee beans
|
WO2019220441A1
(fr)
|
2018-05-15 |
2019-11-21 |
Hadasit Medical Research Services And Development Ltd. |
Compositions et méthodes de traitement du cancer résistant à un agent anticancéreux
|
IL259392A
(en)
|
2018-05-15 |
2018-08-01 |
Yeda Res & Dev |
Vaccination with cancer neo-antigens
|
MX2020012534A
(es)
|
2018-05-27 |
2021-04-28 |
Biolinerx Ltd |
Agi-134 combinado con un inhibidor de punto de control para el tratamiento de tumores solidos.
|
CA3102975A1
(fr)
|
2018-06-07 |
2019-12-12 |
The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization (Aro) (Volcani Center) |
Procedes de regeneration et de transformation de cannabis
|
WO2019234754A1
(fr)
|
2018-06-07 |
2019-12-12 |
The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization (Aro) (Volcani Center) |
Constructions d'acide nucléique et procédés d'utilisation de celles-ci
|
WO2020003311A1
(fr)
|
2018-06-25 |
2020-01-02 |
Yeda Research And Development Co. Ltd. |
Systèmes et procédés permettant d'améliorer l'efficacité de l'édition génomique
|
WO2020008412A1
(fr)
|
2018-07-04 |
2020-01-09 |
Ukko Inc. |
Procédés de ré-épitopage de protéines de blé et leur utilisation pour le traitement de maladie cœliaque
|
EP3818529A2
(fr)
|
2018-07-08 |
2021-05-12 |
Yeda Research and Development Co. Ltd |
Évaluation spécifique à une personne de la sensibilité aux probiotiques
|
EA202190249A1
(ru)
|
2018-07-11 |
2021-05-21 |
Иммунити Фарма Лтд. |
Пептидные соединения и их терапевтическое применение
|
SG11202013167UA
(en)
|
2018-07-11 |
2021-01-28 |
Kahr Medical Ltd |
SIRPalpha-4-1BBL VARIANT FUSION PROTEIN AND METHODS OF USE THEREOF
|
BR112021001586A2
(pt)
|
2018-07-31 |
2021-05-04 |
Collplant Ltd. |
evento transgênico do tabaco e métodos para detecção e uso dos mesmos
|
IL261156A
(en)
|
2018-08-14 |
2020-02-27 |
Fass Deborah |
Chimeric quiescin sulfhydryl oxidase (qsox1) antibodies and uses of same
|
CN113227359A
(zh)
|
2018-08-24 |
2021-08-06 |
耶达研究及发展有限公司 |
调节m2巨噬细胞极化的方法及其在治疗中的用途
|
CN113038951A
(zh)
|
2018-09-20 |
2021-06-25 |
耶达研究及发展有限公司 |
治疗肌萎缩侧索硬化的方法
|
US20210338767A1
(en)
|
2018-09-25 |
2021-11-04 |
Biolinerx Ltd. |
Methods of selecting treatment for cxcr4-associated cancer
|
IL262658A
(en)
|
2018-10-28 |
2020-04-30 |
Memorial Sloan Kettering Cancer Center |
Prevention of age related clonal hematopoiesis and diseases associated therewith
|
IL263184A
(en)
|
2018-11-21 |
2020-05-31 |
Yarden Yosef |
Method of treating cancer and compositions for same
|
WO2020152686A1
(fr)
|
2019-01-23 |
2020-07-30 |
Yeda Research And Development Co. Ltd. |
Milieux de culture pour cellules souches pluripotentes
|
IL264768A
(en)
|
2019-02-10 |
2020-08-31 |
Sagi Irit |
ANTI-MATRIX METALLOPROTEINASE 7 (MMP-7) inhibitory antibody and its use
|
IL264854A
(en)
|
2019-02-14 |
2020-08-31 |
Bahat Anat |
Spt5 inhibitors and methods of use thereof
|
WO2020170239A1
(fr)
|
2019-02-21 |
2020-08-27 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Procédés de génération d'organoïdes pour criblage à haut rendement de médicaments
|
EP3927378A1
(fr)
|
2019-02-21 |
2021-12-29 |
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. |
Procédé de réduction d'une néphrotoxicité induite par des médicaments
|
WO2020178822A1
(fr)
|
2019-03-05 |
2020-09-10 |
The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization (Aro) (Volcani Center) |
Oiseaux à édition de génome
|
GB201903519D0
(en)
|
2019-03-14 |
2019-05-01 |
Tropic Biosciences Uk Ltd |
Introducing silencing activity to dysfunctional rna molecules and modifying their specificity against a gene of interest
|
GB201903521D0
(en)
|
2019-03-14 |
2019-05-01 |
Tropic Biosciences Uk Ltd |
No title
|
GB201903520D0
(en)
|
2019-03-14 |
2019-05-01 |
Tropic Biosciences Uk Ltd |
Modifying the specificity of non-coding rna molecules for silencing genes in eukaryotic cells
|
IL265486A
(en)
|
2019-03-19 |
2020-09-30 |
Yeda Res & Dev |
Bistable type ii opsins and uses thereof
|
WO2020194317A1
(fr)
|
2019-03-28 |
2020-10-01 |
Yeda Research And Development Co. Ltd. |
Méthode de traitement de troubles liés aux lipides
|
WO2020202142A2
(fr)
|
2019-03-31 |
2020-10-08 |
Yeda Research And Development Co. Ltd. |
Composés anti-viraux et anti-tumoraux
|
IL266433B
(en)
|
2019-05-02 |
2020-11-30 |
Sagi Irit |
Compositions comprising the propeptide of lysyl oxidase and uses thereof
|
EP3969619A1
(fr)
|
2019-05-13 |
2022-03-23 |
Yeda Research and Development Co. Ltd |
Biomarqueurs de micro-adn acellulaire pour le pronostic et le diagnostic de maladies neurodégénératives
|
IL266728B
(en)
|
2019-05-19 |
2020-11-30 |
Yeda Res & Dev |
Identification of recurrent mutant neopeptides
|
US20220213445A1
(en)
|
2019-05-22 |
2022-07-07 |
Hadasit Medical Research Services And Development Ltd. |
Methods of culturing human pluripotent cells
|
EP3976646A4
(fr)
|
2019-05-28 |
2023-04-19 |
Shanghaitech University |
Composition et méthodes pour le traitement d'une dysplasie ectodermique 2, type clouston
|
EP3983531A1
(fr)
|
2019-06-12 |
2022-04-20 |
Hadasit Medical Research Services and Development Ltd. |
Procédés de génération d'oligodendrocytes
|
US20220307008A1
(en)
|
2019-06-16 |
2022-09-29 |
Yeda Research And Development Co. Ltd. |
Method for stabilizing intracellular rna
|
WO2020261281A1
(fr)
|
2019-06-27 |
2020-12-30 |
Ramot At Tel-Aviv University Ltd. |
Anticorps semaphorine 3a et leurs utilisations
|
CN114938647A
(zh)
|
2019-07-04 |
2022-08-23 |
乌科公司 |
去表位的α-麦醇溶蛋白及其在乳糜泻和麸质敏感性管理中的用途
|
MX2022000367A
(es)
|
2019-07-11 |
2022-07-13 |
Kahr Medical Ltd |
Heterodimeros, metodos y uso de los mismos.
|
WO2021009740A1
(fr)
|
2019-07-16 |
2021-01-21 |
Ramot At Tel-Aviv University Ltd. |
Compositions et procédés pour le traitement de la tuberculose
|
IL268111A
(en)
|
2019-07-16 |
2021-01-31 |
Fainzilber Michael |
Methods of treating pain
|
WO2021019526A1
(fr)
|
2019-07-29 |
2021-02-04 |
Yeda Research And Development Co. Ltd. |
Procédés de traitement et de diagnostic du cancer du poumon
|
US20220298522A1
(en)
|
2019-07-30 |
2022-09-22 |
The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization |
Methods of controlling cannabinoid synthesis in plants or cells and plants and cells produced thereby
|
WO2021028909A1
(fr)
|
2019-08-12 |
2021-02-18 |
Yeda Research And Development Co. Ltd. |
Test sanguin de réparation de l'adn pour prédire la réponse de patients atteints d'un cancer du poumon à une immunothérapie
|
WO2021033176A1
(fr)
|
2019-08-22 |
2021-02-25 |
Ariel Scientific Innovations Ltd. |
Procédés mis à l'échelle de purification d'anticorps
|
EP4021463A1
(fr)
|
2019-08-27 |
2022-07-06 |
Yeda Research and Development Co. Ltd |
Traitement de la vaginose bactérienne
|
WO2021048852A1
(fr)
|
2019-09-11 |
2021-03-18 |
Yeda Research And Development Co. Ltd. |
Méthodes de traitement du cancer du sein
|
IL269674B
(en)
|
2019-09-25 |
2020-08-31 |
Roy Bar Ziv |
Assembling protein complexes on a chip
|
IL270306A
(en)
|
2019-10-30 |
2021-05-31 |
Yeda Res & Dev |
Prevention and treatment of pre-myeloid and myeloid malignancies
|
WO2021084526A1
(fr)
|
2019-10-31 |
2021-05-06 |
Yeda Research And Development Co. Ltd. |
Bactéries autotrophes génétiquement modifiées pour la conversion de co2 en matériaux organiques
|
US20220386594A1
(en)
|
2019-11-11 |
2022-12-08 |
Ibi-Ag Innovative Bio Insecticides Ltd. |
Insect control nanobodies and uses thereof
|
AU2019474716A1
(en)
|
2019-11-19 |
2022-07-07 |
Protalix Ltd. |
Removal of constructs from transformed cells
|
IL270800A
(en)
|
2019-11-20 |
2021-05-31 |
Yeda Res & Dev |
A method for treating Alzheimer's disease
|
IL271656A
(en)
|
2019-12-22 |
2021-06-30 |
Yeda Res & Dev |
System and methods for identifying cells that have undergone genome editing
|
EP4077731A1
(fr)
|
2019-12-22 |
2022-10-26 |
Yeda Research and Development Co. Ltd |
Diagnostic de la démence frontotemporale
|
US20230048361A1
(en)
|
2019-12-31 |
2023-02-16 |
Kahr Medical Ltd. |
Methods of culturing t cells and uses of same
|
IL271778A
(en)
|
2019-12-31 |
2021-06-30 |
Ichilov Tech Ltd |
Methods for treating atopic dermatitis
|
WO2021137231A1
(fr)
|
2019-12-31 |
2021-07-08 |
Kahr Medical Ltd. |
Procédés de culture de lymphocytes t avec un polypeptide de fusion 4-1bbl et leurs utilisations
|
IL272074A
(en)
|
2020-01-15 |
2021-07-29 |
Immunity Pharma Ltd |
Peptide compounds and their use in methods of treating diseases
|
IL272194A
(en)
|
2020-01-22 |
2021-07-29 |
Yeda Res & Dev |
Multi-target antibodies for use in the treatment of diseases
|
WO2021152584A1
(fr)
|
2020-01-28 |
2021-08-05 |
Ariel Scientific Innovations Ltd. |
Procédés d'analyse de membranes cellulaires
|
WO2021152587A1
(fr)
|
2020-01-30 |
2021-08-05 |
Yeda Research And Development Co. Ltd. |
Traitement d'une maladie hépatique aiguë à l'aide d'inhibiteurs de tlr-mik
|
IL272390A
(en)
|
2020-01-30 |
2021-08-31 |
Yeda Res & Dev |
Cancer treatment methods
|
WO2021152586A1
(fr)
|
2020-01-30 |
2021-08-05 |
Yeda Research And Development Co. Ltd. |
Procédés d'analyse du microbiome, du profil d'immunoglobuline et de l'état physiologique
|
IL272389A
(en)
|
2020-01-30 |
2021-08-31 |
Yeda Res & Dev |
Kits containing antibodies to PD-L1 and their uses in therapy
|
IL295500A
(en)
|
2020-02-09 |
2022-10-01 |
Nlc Pharma Ltd |
Rapid detection test for sars-cov-2
|
IL272586A
(en)
|
2020-02-10 |
2021-08-31 |
Yeda Res & Dev |
A method for cell cluster analysis
|
WO2021173674A1
(fr)
|
2020-02-26 |
2021-09-02 |
A2 Biotherapeutics, Inc. |
Polypeptides ciblant des complexes mage-a3 peptide-mhc et leurs méthodes d'utilisation
|
EP4121441A1
(fr)
|
2020-03-16 |
2023-01-25 |
Yeda Research and Development Co. Ltd |
Analogues peptidiques et leur utilisation dans le traitement de maladies, troubles ou états associés à une protéine p53 mutante
|
BR112022019510A2
(pt)
|
2020-03-29 |
2022-11-16 |
Yeda Res & Dev |
Variantes de beta-glucocerebrosidase para uso no tratamento de doença de gaucher
|
US20240000857A1
(en)
|
2020-03-31 |
2024-01-04 |
Biomuse Ltd. |
Bacteria for the prevention and treatment of smoke-induced lung damage
|
WO2021205444A1
(fr)
|
2020-04-06 |
2021-10-14 |
Yeda Research And Development Co. Ltd. |
Méthodes de diagnostic du cancer et de prédiction de la réactivité à une thérapie
|
EP4132479A1
(fr)
|
2020-04-07 |
2023-02-15 |
Ramot at Tel-Aviv University Ltd. |
Compositions contenant du cannabidiol et leurs utilisations
|
IL297228A
(en)
|
2020-04-13 |
2022-12-01 |
Exoprother Medical Ltd |
Cellular vesicles containing non-mutant p53 for antiviral therapy
|
US20210322483A1
(en)
|
2020-04-16 |
2021-10-21 |
Ichilov Tech Ltd. |
Cell-derived particles presenting heterologous cd24 and use thereof in therapy
|
WO2021229577A1
(fr)
|
2020-05-12 |
2021-11-18 |
Collplant Ltd. |
Collagène utilisé comme outil d'administration d'agents antiviraux à base de métaux
|
IL274811B
(en)
|
2020-05-20 |
2021-05-31 |
Yeda Res & Dev |
Spatial information is developed for the analysis of individual cells
|
WO2021260675A1
(fr)
|
2020-06-24 |
2021-12-30 |
Yeda Research And Development Co. Ltd. |
Agents pour sensibiliser des tumeurs solides à un traitement
|
IL276599A
(en)
|
2020-08-09 |
2022-03-01 |
Yeda Res & Dev |
T cell receptor unique to mage-a1 and its uses
|
IL276627A
(en)
|
2020-08-10 |
2022-03-01 |
Yeda Res & Dev |
Compositions for diagnosis and treatment of coronavirus infections
|
WO2022038536A1
(fr)
|
2020-08-18 |
2022-02-24 |
International Rice Research Institute |
Procédés d'augmentation des taux de croisement de gramineae
|
IL277488A
(en)
|
2020-09-21 |
2022-04-01 |
Yeda Res & Dev |
Weight regulation method
|
IL301503A
(en)
|
2020-09-23 |
2023-05-01 |
Yeda res & development co ltd |
Methods and preparations for the treatment of the disease caused by the corona virus
|
IL277743A
(en)
|
2020-10-01 |
2022-04-01 |
Yeda Res & Dev |
A method for diagnosing breast cancer
|
US20230374447A1
(en)
|
2020-10-05 |
2023-11-23 |
Protalix Ltd. |
Dicer-like knock-out plant cells
|
EP4225903A1
(fr)
|
2020-10-07 |
2023-08-16 |
Protalix Ltd. |
Dnase à action prolongée
|
EP4228637A1
(fr)
|
2020-10-15 |
2023-08-23 |
Yeda Research and Development Co. Ltd |
Méthode de traitement des cancers myéloïdes
|
IL278401A
(en)
|
2020-10-29 |
2022-05-01 |
Yeda Res & Dev |
Polynucleotides for editing RNA and a method for using them
|
US20230416750A1
(en)
|
2020-11-09 |
2023-12-28 |
1E Therapeutics Ltd. |
Catalytic sequence based methods of treating or preventing bacterial infections
|
AU2021387979A1
(en)
|
2020-11-26 |
2023-03-30 |
Ukko Inc. |
Modified high molecular weight glutenin subunit and uses thereof
|
IL279559A
(en)
|
2020-12-17 |
2022-07-01 |
Yeda Res & Dev |
Controlling the ubiquitination process of mlkl for disease treatment
|
EP4267741A2
(fr)
|
2020-12-28 |
2023-11-01 |
1E Therapeutics, Ltd. |
Zones cibles de l'arnm p21 pour le silençage
|
KR20230133859A
(ko)
|
2020-12-28 |
2023-09-19 |
1이 테라퓨틱스 엘티디. |
p21 mRNA 표적화 DNA자임
|
AU2022206415A1
(en)
|
2021-01-10 |
2023-08-17 |
Supermeat The Essence Of Meat Ltd. |
Pluripotent stem cell aggregates and microtissues obtained therefrom for the cultured meat industry
|
WO2022153286A1
(fr)
|
2021-01-14 |
2022-07-21 |
Yeda Research And Development Co. Ltd. |
Procédés de production de vitamine d
|
IL280340B
(en)
|
2021-01-21 |
2022-04-01 |
Yeda Res & Dev |
Antibodies, peptides and their combinations for the treatment and prevention of corona virus infections
|
JP2024506954A
(ja)
|
2021-02-18 |
2024-02-15 |
イェダ リサーチ アンド デベロップメント カンパニー リミテッド |
ワクチン作製用の遺伝子改変細菌
|
CA3208982A1
(fr)
|
2021-02-18 |
2022-08-25 |
Ravid STRAUSSMAN |
Procede de generation de vaccins
|
IL281561A
(en)
|
2021-03-16 |
2022-10-01 |
Yeda Res & Dev |
Methods and devices for growing mouse embryos outside the uterus
|
WO2022208369A1
(fr)
|
2021-03-30 |
2022-10-06 |
Biomx Ltd. |
Bactériophage de pseudomonas et ses utilisations
|
IL282188A
(en)
|
2021-04-08 |
2022-11-01 |
Yeda Res & Dev |
Combined use of ketamine and bretigabine for the treatment of psychiatric disorders
|
AU2022272135A1
(en)
|
2021-05-12 |
2024-01-04 |
Biomx Ltd. |
Staphylococcus bacteriophage and uses thereof
|
IL283563A
(en)
|
2021-05-30 |
2022-12-01 |
Yeda Res & Dev |
Profiling of amps for the diagnosis, monitoring and treatment of microbiome-related diseases
|
IL309061A
(en)
|
2021-06-06 |
2024-02-01 |
Yeda res & development co ltd |
Combined cancer treatment
|
CN117836402A
(zh)
|
2021-06-13 |
2024-04-05 |
耶路撒冷希伯来大学伊森姆研究发展有限公司 |
重编程人细胞的方法
|
NL2028466B1
(en)
|
2021-06-16 |
2022-12-21 |
Sakata Holland B V |
Methods of sorting matthiola seeds
|
CR20240020A
(es)
|
2021-06-16 |
2024-02-28 |
Seedx Tech Inc |
Métodos de clasificación de semillas de matthiola
|
WO2023275255A1
(fr)
|
2021-07-02 |
2023-01-05 |
Tropic Biosciences UK Limited |
Retardement ou prévention du brunissement de bananes
|
CA3226076A1
(fr)
|
2021-07-18 |
2023-01-26 |
Tracey Lodie |
Populations de cellules nk therapeutiques
|
WO2023002492A1
(fr)
|
2021-07-22 |
2023-01-26 |
Yeda Research And Development Co. Ltd. |
Optimisation de codon d'acides nucléiques
|
EP4130028A1
(fr)
|
2021-08-03 |
2023-02-08 |
Rhazes Therapeutics Ltd |
Complexe tcr modifié et leurs procédés d'utilisation
|
KR20240040770A
(ko)
|
2021-08-03 |
2024-03-28 |
제니시티 리미티드 |
조작된 tcr 복합체 및 이의 사용 방법
|
WO2023018621A1
(fr)
|
2021-08-10 |
2023-02-16 |
Gamida-Cell Ltd. |
Cellules nk modifiées, leurs procédés de production et leurs utilisations
|
GB202112865D0
(en)
|
2021-09-09 |
2021-10-27 |
Tropic Biosciences Uk Ltd |
Resistance to black sigatoka disease in banana
|
GB202112866D0
(en)
|
2021-09-09 |
2021-10-27 |
Tropic Biosciences Uk Ltd |
Resistance to fusarium wilt in a banana
|
IL286430A
(en)
|
2021-09-14 |
2023-04-01 |
Yeda Res & Dev |
Multispecific antibodies for use in the treatment of diseases
|
WO2023105526A1
(fr)
|
2021-12-08 |
2023-06-15 |
Yeda Research And Development Co. Ltd. |
Cellules progénitrices pulmonaires multipotentes pour la régénération pulmonaire
|
WO2023209708A1
(fr)
|
2022-04-25 |
2023-11-02 |
Yeda Research And Development Co. Ltd. |
Compositions pour modifier la signalisation de messager secondaire de l'adp-ribose cyclique
|